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Résumé 
La phosphorylation des protéines joue un role primordial dans les voies de 
signalisation cellulaire. De récents progrès en spectrométrie de masse (MS) permettent 
l'identification de milliers de sites de phosphorylation. Cependant, l'inefficacité 
d'ionisation des phosphopeptides limite leur détection. Ce travail présente une méthode 
d'identification des phosphopeptides à partir d'extraits cellulaires enrichis avec Ti02 et 
déphosphorylés par la phosphatase alcaline. La corrélation des temps de rétention de 
plus de 750 paires de phospho- et déphosphopeptides indique que les changements 
d'hydrophobicité sont partiellement expliqués par l'interaction électrostatique avec des 
/ 
acides aminés basiques. Une augmentation d'au moins un facteur de 2 dans le nombre 
de phosphopeptide détectables a été observée suite à la déphosphorylation. Cette 
méthodologie a été appliquée à des extraits cellulaires de macrophage 1774 traités ou 
non à l'interféron-gamma (IFN-y) et a permis l'identification de phosphoprotéines 
impliquées dans différentes voies de signalisation. 
Le profil cinétique du phosphoprotéome des cellules 1774 stimulées par IFN-y 
(jusqu'à 180 min) et enrichis avec Ti02 a été obtenu pour mieux comprendre l'effet 
biologique de l'IFN-y sur les macrophages. Des changements significatifs de 
phosphorylation ont été observés à 5 et 30 min après stimulation. L'analyse par 2D-LC-
MS/MS des macrophages stimulés pendant 5 et 30 min par l'IFN-y a permis 
l'identification de 2831 phosphopeptides incluant 1673 nouveaux sites de 
phosphorylation. L'analyse du réseau d'Întéraction des phosphoprotéines a permis 
d'identifier des protéines impliquées dans les voies de signalisation du complexe 
NADPH oxydase (p67phox), des phospholipides (SHIP-2), de la traduction de ARNm 
(eIF4B) et de l'apoptose (PEA-15, NF-KB). 
Mots-clés: Phosphorylation, spectromètre de masse, profil d'expression, enrichissement 
par Ti02, IFN-y, macrophages, phosphatase alcaline, réseau d'interactions 
protéine-protéine, voies de signalisation, prédiction de kinases. 
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Abstract 
In biological systems, signal transduction pathways are primarily guided through 
various prote in phosphorylation and dephosphorylation events. Major analytical 
advances in mass spectrometry have enabled the direct identification of protein 
phosphorylation sites in complex mixtures. Yet, phosphoproteome analyses are still 
quite challenging due to the poor ionization efficiency of phosphopeptides. This work 
presents a combined enzymatic and data mining approach enabling more than 2-fold 
increase of phosphopeptides detection following alkaline phosphatase digestion of 
TiOz-enriched J774 cell ex tracts. The retenti on time of more than 750 phosphopeptides 
was shifted toward higher and lower values compared to their dephosphory lated 
counterpart. The loss in hydrophobicity is partially explained by the electrostatic 
interaction of the phosphate group with basic amino groups. This approach was applied 
to 5 min interferon-gamma (IFN-y) treated mouse macrophage cells and led to the 
identification of key IFN-y signaling events. 
Furthermore, activated signaling transductions were more clearly defined to 
understand IFN-y biological effects on macrophages. We compared the temporal 
changes in the phosphoproteome of TiOz-enriched J774 macrophages following IFN-y 
stimulation (up to 180 min). Amongst the different trends observed, most significant 
changes in phosphorylation occurred to the same extent 5 and 30 min after IFN-y 
induction. The 2D-LC-MS/MS analysis on TiOz-enriched 5 and 30 min IFN-y treated 
macrophages identified a total of 2831 phosphopeptides including 1673 novel 
phosphorylation sites. Network analyses of differentially regulated phosphopeptides led 
to the identification of early signaling and regulatory events including members of the 
NADPH complex (p67Phox), phospholipids (SHIP-2), protein synthesis (eIF4B) and 
apoptotic (PEA-IS, NFK:B) pathways. 
Key words: Phosphorylation, mass spectrometry, expression profiling, TiOz 
enrichment, IFN-y, macrophages, alkaline phosphatase, protein network, 
signaling pathways, kinase prediction. 
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1. General Introduction 
2 
1.1 Project's goal 
Upon IFN-y stimulation, macrophages are primed to prote ct the organism against 
infectious diseases [1]. With the exception of the classical anti-inflammatory JAK-STAT 
pathway [2], no other important IFN-y stimulated pathways are completely characterized to 
fully understand the cell defence mechanism against invading pathogens [3]. The JAK-
ST AT pathway was also one of the first pathways demonstrating that phosphorylation plays 
a central role during IFN-y activated cell signaling. Since only a small fraction of 
phosphoproteins is phosphorylated at any given time, powerful and sensitive tools like 
mass spectrometry are required for their detection [4]. 
In this context, the goal of this thesis consists of evaluating the phosphoproteome of 
intracellular signa1ing pathways in IFN-y treated macrophages using mass spectrometry 
approaches. Phosphopeptide analysis by mass spectrometry is still limited since 
phosphorylated peptides do not efficiently ionize in positive ion mode due to their negative 
charge contribution [5]. Hence, the first part of this project will focus on the development 
and optimization of a novel technique for a higher phosphopeptide identification level. The 
method consists of treating ha If of the Ti02-enriched phosphopeptide samples with alkaline 
phosphatase. The treated and non-treated chromatograms will be subsequently compared 
using in-house bioinformatic tools. Removal of the phosphate group is expected to not 
only enhance phosphopeptides detection but may also provide interesting feedback on 
phosphopeptide behaviour in MS. Following validation of the enzymatic approach, the 
method will be applied on 1774 mouse macrophages to determine changes in 
phosphorylation occurring upon IFN-y stimulation. 
The second part of the study covers the evaluation of the phosphoproteome 
dynamics of IFN-y treated macrophages. High-throughput phosphoproteomic strategies 
su ch as strong-cation exchange (SCX) chromatography combined with Ti02 enrichment 
will be used to analyse the phosphoproteome changes of macrophages treated with the 
optimal cytokine incubation time. Furthermore, differentially expressed phosphoproteins 
will be identified using in-house softwares su ch as Mass Sense and peptide c1ustering. The 
last part of the analysis will combine kinase and motif prediction assays with protein 
networking to determine activated signaling pathways mediating important IFN-y 
biological effects. 
3 
1.2 Innate immunity 
Infectious diseases are the major cause of death and health problems in our society 
[6]. Innate and adaptive immune systems evolved to prevent and control the formation of 
inflammation diseases [7]. The innate immune system is the first line of defence against 
invading organisms with receptors recognizing the molecular structure of pathogens. For 
instance, Toll-like receptors (TLRs) identify the bacterial cell wall components and 
pathogen nucleic acids to subsequently activate intracellular signaling [8]. The innate 
immune system will also trigger the adaptive immune system by inducing pro-
inflammatory cytokines, which will activate specialized cells and antibody production [8]. 
Macrophages are specialized cells responsible for the elimination of pathogens and 
cell debris from the system. The presence of inflammatory signaIs warn macrophages of 
viral andmicrobial infection [9]. The most important cytokine activation signal is 
interferon-gamma (IFN-y). IFN-y induces transcriptional regulation and activates signal 
transduction pathways involved in cytoskeletal reorganization, phospholipids composition, 
cell viability and protein synthesis, enabling the cell to fight invading micro-organisms [3, 
10, Il]. 
1.2.1 Macrophages and inflammation 
Inflammation response consists of the release of cytokines by T cells upon detection 
of micro-organisms and the recruitment of specialized cells such as macrophages that will 
in tum also further release mediators [10]. The name "macrophage" actually relates to 
"large eater" entailing that thesecells clear invading micro-organisms. Macrophages can be 
stimulated by different types of innate and acquired immune activation systems su ch as the 
tumor necrosis factor-alpha (TNF-a) and IFN-y. The classical activation of macrophages is 
mediated by IFN-y and can be enhanced by a microbial trigger such as bacterial 
lipopolysaccharide (LPS) [12]. Binding of microbialligands to phagocytic receptors on the 
macrophage activates and promotes changes in gene transcription and protein expression 
[2]. On the other hand, suppressors of cytokine signaling (SOCS) and cytokine-inducible 
4 
SH2 protein (CrS) negatively regulate cytokine activation to prevent over reaction of 
cytokines [13]. 
During inflammation, primed macrophages are versatile cells that play three 
important roles. Initially, these activated cells will engulf the foreign particle and form 
organelles called phagosomes. In these phagosomes, macrophages kill microbes by the 
production of nitric oxide and superoxide, the reduction of pH by the v-ATPase and the 
acquisition of hydrolases and proteases by fusion with endosomes and lysosomes [12]. 
IFN-y aiso enhances the transcription of major histocompatibility complex (MHC) class 1 
and II molecules, that will present microbial peptides, sugars and lipids to the cell surface 
[14]. Finally, several pro-inflammatory cytokines, enzymes and regulatory factors including 
IL-l and IL-6 are secreted by activated macrophages to regulate the immune response and 
the development of inflammation [12]. This whole process results into activation of the 
adaptive and innate immune response [7]. 
Due to their major role in defending the organism by phagocytosis, macrophages 
are implicated in many infectious diseases of the immune system. For instance, 
macrophages are involved in atherosc1erosis and targets of specific pathogens such as 
Mycobacterium tuberculosis or trypanosomes of the Leishmania genus [14-16]. Since 
cytokines are responsible to form the n€twork of communication signaIs between the cells 
of the immune system, the se molecules are often used as therapeutic agents [16, 17]. 
1.2.2 IFN-y signaling pathways 
IFNs are widely expressed pleiotropic cytokines classified into two categories, type 
1 and II. IFN-y is the only type II IFN and is structurally unrelated to type L IFN-y is mostly 
produced by CD4+ T cells and has a strong anti-viral effect [9, 18]. Macrophages are 
capable to overcome inflammation through a multitude of activated signaling pathways 
responsible to mediate the IFN-y biological effects. 
5 
1.2.2.1 Transcriptional regulation 
The first signaling pathway shown to be activated by lFNs was the JAK-STA T 
pathway. IFN-y receptor 1/2 (IFNGR1/2) binds to IFN-y molecules which then triggers the 
recruitment of Janus activated kinase 1/2 (Jak1l2) for the initiation of signal transduction 
[2]. Activated Jakl phosphorylates signal transducers and activators of transcription 1 
(Statl) proteins which will in turn dimerize and translocate to the nucleus (Fig. 1.1) [19]. 
Stat 1 phosphorylation is necessary for full transcriptional activation [3 J. This cascade of 
tyrosine and serine phosphorylation is known to occur very promptly, in less than 1 min 
[9]. 
ÎFN-y 
r IFNGRj -~- --
1 1/2 ~_~ J AK2 J AKI ~"",~-'-".J'''''#_'''''''''' 
-:; 
,IRF-9 ,+ :ATI 
IRF-9 
Figure 1.1: The classical JAK-STA T pathway following IFN-y stimulation of 
macrophages. Ligand binding induces confonnational changes of IFNGR1I2, 
which will translocate Jak1l2 to the membrane. Stimulated Jakl will 
phosphorylate tyrosine residues on the lFNGR 1/2 receptor to allow 
recruitment ofStatl. Following tyrosine phosphorylation and lRF-9 binding in 
the cytoplasm, Statl fonns a homodimer. Dimerized Statl translocates to the 
nucleus and binds the lFN-stimulated response element (ISRE) to initiate or 
suppress transcription of lFN-y-regulated genes. 
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Statl can even function with IFN regulatory factors (IRFs) to establish the delayed 
response entailing the assurance of proper transcription control for the antiviral state (Fig. 
1.1) [20]. On the other hand, Jak kinase activity is negatively regulated by SOCS-l and 
SOCS-3 proteins [9]. These Jak kinase inhibitor proteins bind to the phosphorylated 
tyrosine residue on IFNGRI and mask Statl docking site [10]. 
In addition to Jak-Stat pathway, other IFN-y signaling pathways involving key 
molecules such as NF-KB and phosphatidylinositol 3-kinase (PI3K), lead to changes in 
transcription control as part of the inflammation response [21, 22]. 
1.2.2.2 Cell growth and apoptosis 
The effect of IFN-y on apoptosis in macrophages is still subject to controversy. 
Several studies show that apoptosis is induced by IFN-y, whereas others report that it serves 
as an anti-apoptotic signal [9, 23]. IFNs can activate the PI3K-Akt signaling pathway, and 
generate either pro-survival or apoptotic signaIs depending on the cellular context [3, 24]. 
In most cases, survival of the cell is crucial for the generation of IFN-y induced proteins 
necessary for the destruction of the invading organism [3]. On the other hand, apoptosis 
might also be the right choice for the destruction of tumor cells. For instance, IFN-y 
induces up-regulation of Fas protein which is responsible for the activation of cell death 
[25]. 
The anti-apoptotic transcription factor, NF-KB, is stimulated by proinflammatory 
cytokines and plays a crucial role in macrophages [26]. NF-kB regulates genes responsible 
for both the innate and the adaptive immune response [21]. In resting cells, NF-KB is bound 
to IKB protein and remains inactive in the cytoplasmic compartment. Extracellular 
stimulation induces signaling pathways that converge to free NF-KB from IKB [10]. NF-KB, 
then translocates to the nucleus to regulate the expression of multiple target genes to 
respond to the inflammation, the immune response, inflammatory response, cell adhesion, 
cell growth, and apoptosis (Fig. 1.2) [21]. 
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Figure 1.2: The c1assical NF-KR signaling pathway during inflammatory response. Pro-
inflammatory cytokines su ch as IFN-y and TNF-a activate tumour necrosis 
factor receptor 1 (TNFR 1) which triggers silencer of death domain (SODD) 
release and recruitment of TNF-receptor-associated death domain prote in 
(TRADD), receptor-interacting protein (RIP) and TNF-receptor-associated 
factor 2 (TRAF2) to the membrane. Subsequently, hcB kinase (lKK)-complex 
is recruited to the TNFR 1 receptor by TRAF2 [21]. Activated IKK 
phosphorylates hcB, which indu ces confonnational change of hcB and exposes 
lysine residues for ubiquination. Thus, IKB becomes target for degradation by 
26S proteasome and releases NF-KB dimers (p50 & p65) from the cytoplasmic 
NF-KB-IKB complex [10]. Free NF-KB translocates to the nucleus and binds to 
DNA for the regulation of gene transcription. 
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1.2.2.3 mRNA translation 
IFN-y can also block cell growth and inhibit viral replication by deactivating the 
mRNA translation protein machinery. Most invading organisms su ch as bacteria and 
parasites have their own metabolism and only rely on the host for nutrients. On the other 
hand, viruses take over the host's protein synthesis machinery for their own repli cation 
[27]. For example, poliovirus and influenza virus specifically shut down the transcription 
and protein synthesis machinery respectively of the host cell so that the host cell 
replication, transcription and translation machinery will be dedicated for the synthesis of 
viral proteins [7]. 
IFN-y activation will mai nI y inhibit the translation of viral mRNAs during virus replication. 
The dsRNA will activate IFN-inducible RNA-dependent protein kinase (PKR), which will 
in tum phosphorylate eIF-2a subunit to inactivate viral prote in synthesis [28]. 
On the other hand, IFN is also known to induce protein expression of IFN-sensitive 
genes that act as direct or indirect mediators of their biological effect. Since prote in 
synthesis requires considerable amounts of metabolic energy (A TP & GTP) and amine 
acids, this event is highly controlled [3]. The initiation step corresponds to the decisive 
point during mRNA translation to deterrnine the fate of protein synthesis. Hence, 
extracellular stimuli mediate signal transduction oftwo different pathways (Ras-MAPK and 
PI3K1 AktimTOR), which converge and rigorously regulate the specific activity of key 
initiation translation factors (Fig. 1.3) [22, 29, and 30]. 
In summary, IFN-y stimulation was demonstrated to be directly involved in 
blocking virus repli cation and in the synthesis of critical proteins for the inflammation 
response. Yet, similarly to apoptosis, the precise role of IFN-y effect on mRNA translation 
is still not c1early defined [3]. 
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Figure 1.3: IFN-y activation of Ras-MAPK and PI3KJAkt/mTOR signaling pathways 
to initiate mRNA translation. IFN-y induction leads to the activation of the 
PI3K and Ras pathways [29]. Consequently, PDKI and ERK1/2 
phosphorylate and stimulate ribosomal protein S6 kinases (RSKs) [22]. AIso, 
activated mammalian target of rapamycin (mTOR) phosphorylates 4EBP 1, 
eIF4G and p70 S6K. Induced p70 S6K kinase and RSKs phosphorylate eIF4B 
resulting in initiation of mRNA translation [31]. In contrast, phosphorylation 
of 4EBP 1 disrupts its interaction with eIF4E. In the free state, eIF4E gets 
phosphorylated by MAP kinase signal-interacting kinase 1/2 (MNK 1/2), 
which activates its binding to the cap for translation initiation [29]. 
1.2.2.4 Phospholipid signaling 
Another major pathway activated in response to extracellular stimuli consists of 
PLCs, phosphoinositide kinases and phosphatases, which are responsible for the change in 
phosphoinositide concentration. As discussed in the mRNA translation signaling pathways, 
PI3K was shown to play a major role upon IFN-y activation. Nonetheless, PI3K also 
produces a potent messenger phospholipid Pl(3,4,5)P3 from PI(4,5)P2. Phosphatase and 
tensin homologue deleted on chromosome ten (PTEN) prote in and inositol polyphosphate 
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phosphatase-like 1 (SHIP-2) can terminate this pathway by transforming Pl(3,4,5)P3 into 
PI(4,5)P2 and PI(3,4)P2, respectively [32]. 
The phosphoinositide, PI(4,5)P2, is involved in large number of cellular processes 
such as cell survival, membrane transport and bacterial uptake and transport. For example, 
PI( 4,5)P2 participates in the cytoskeleton remodelling by promoting actin filaments 
polymerization to form pseudopods. Activated macrophages develop membrane protus ions 
for locomotion and final capture of the prey [33]. Figure lA clearly illustrates the cell 
morphology change upon 24 h IFN-y stimulation. 
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Figure 1.4: Microscopie examination of J774 macrophage cells highlighting 
morphological changes taking place upon IFN-y stimulation. 
Furthermore, hydrolysis of PI(4,5)P2 leads to the production of arachidonic acid (AA), 
which also plays an important role in inflammatory response. Once AA is released, it 
interacts with the cytosolic factor, p47phox , further involved in the activation of the NAPDH 
oxidase complex [34]. Interestingly, the change in phospholipid composition within 
macrophages in response to IFN-y leads not only to cytoskeleton rearrangements but also 
the induction of cytotoxic molecules. 
1.2.2.5 Production of cytotoxic mo/ecu/es 
To completely eliminate the invading organlsm, macrophages need to produce 
specific hannful metabolites. To do so, IFN-y-activated macrophages produce two types of 
strong cytotoxic molecules, reactive oxidative species (ROS) and reactive nitrogen species 
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(RNS) by induction of the NADPH-dependent phagocyte oxidase [9]. The NADPH 
complex is localized in the plasma membrane of the phagocytic cup and is composed of 
cytochrome b558 (gp91 phox and gp22phOX ), p47PhoX, p40Phox and p67phox , Rac and Rap l. 
Superoxide (02-) is produced in the phagosome by accepting electrons from the NADPH 
oxidase complex from the cytosolic side of the membrane [35]. 
The NADPH oxidase complex is only complete and active during macrophage 
stimulation. In resting cells, the components of the complex are located in the cytosolic 
compartment of the cell [35]. Upon IFN-y activation, many different signaling pathways 
lead to its formation. For instance, neutrophil cytosolic factors, p47phox , p40PhOX & p67phox , 
are recruited to the membrane by phosphorylation [35]. p47phox can also be translocated to 
the plasma membrane through the interaction with activated arachidonic acid (Fig. 1.5) 
[36]. Two different signaling pathways originating from the phospholipids and the phox 
proteins converge to synergistically stimulate NADPH oxidase complex. 
Synergistic activation of p47 phox 
by AA and phosphorylation 
Active NAPDH oxidase 
enzyme complex 
~GDI 
Figure 1.5: Upon IFN-y administration, induction of cytosolic factors (p47phoX, p40PhOl 
and p67PhOl) recruitment to the membrane to form the NADPH oxidase 
complex through phosphorylation and interaction with arachidonic acid. 
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ln summary, important pathways su ch as JAK-STAT, P13K-Akt-mTOR, NF-KB, 
and NAPDH oxidase, were shown to be affected by lFN-y activation. These changes in the 
gene and protein regulation, cell survival and phospholipid composition are important to 
prepare the macrophage against viral infection and finally lead to phagocytosis and 
pathogen destruction. 
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1.3 Phosphoproteomics 
Upon extracellular stimuli activation, a cascade of signaling events is triggered to 
transmit the message from the membrane to the nucleus and induce changes in different cell 
function such as cytoskeletal structure, protein expression and gene transcription [37]. The 
proteins engaged in these stimulated pathways may undergo post-translational 
modifications (PTMs) such as ubiquitination, phosphorylation, acetylation and methylation 
to regulate their function, localization, binding specificity and stability [38]. Prote in 
phosphorylation is the most abundant PTM and it is involved in various essential cell 
functions such as cell division, proliferation, apoptosis and protein translocation [39]. In 
eukaryotic cells, the most common phosphorylation occurs on hydroxyamino acids such as 
serine, threonine and tyrosine residues with a ratio of about 1000: 100: 1, respectively (Fig. 
1.6) [40]. 
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Figure 1.6: Chemical structure of phosphorylated serine, threonine and tyrosine 
residues [41). 
Detection of phosphoproteins is rather difficult since only 1-2% of proteins are 
found in the phosphorylated form at any given time during signaling pathways [42]. The 
phosphorylation· status of a particular protein depends upon the equilibrium between the 
activities of the corresponding kinases and phosphatases. Since the phosphatase reaction 
dominates and the phosphate group is very labile, the chance to observe a phosphoprotein is 
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very low [5]. Aiso experimental analysis ofphosphoproteins is not an easy task because the 
phosphoamino acid only corresponds to a small fraction of the whole prote in sequence [40]. 
To counteract these problems, cell biologists use three main techniques for 
phosphoprotein detection: 32p radioactive labeling, Western blotting and 2D-gels. The most 
popular method is 32p radioactive labeling since enrichment of the sample is not required 
and the detection signal is very sensitive (fmol) and quantifiable [42]. Yet, working with 
radioactive substances is not very desirable due to their toxic nature. AIso, 32p labeling can 
be tedious and sometimes even impossible since phosphate turnover rate is slow and only 
small amounts of radioactive phosphate are incorporated and may thereby escape detection 
[37]. 
As an alternative, Western blotting is another very sensitive (fmol) technique, which uses 
mono/poly-clonal antibodies directed against phosphorylated amino acids in order to de te ct 
phosphoproteins transferred from a ID or 2D gel to a membrane [40]. However, serine and 
threonine residues possess a very small and structural1y similar group, which makes it 
harder to obtain selective affinity interaction of the antibody to phosphoserines and 
phosphothreonines and the applicability ofthis method is reduced [37]. 
The last classical technique, 2D-gels, allows high-resolution separation of proteins from a 
complex sample according to their size and isoelectric point. However, 2D-gels analysis 
contains many drawbacks such as low-abundance prote in (ng) detection and solubility 
problems of membrane proteins [43]. These molecular biology tools can provide quick 
information on the presence of one relatively abundant phosphoprotein but cannot identify 
the specific phosphorylation site. As an alternative, mass spectrometry has shown to be an 
excellent approach that surpasses most of the limitations encountered by the classical 
biological methods [42]. 
1.3.1 Mass spectrometry approaches for phosphopeptide detection 
In recent years, mass spectrometry techniques and approaches have been developing 
rapidly and with success for the analysis of the phosphoproteome [5]. Initially, Edman 
degradation in combination with 32p labeling allowed the peptide identification of many 
proteins including the phosphoprotein, p-casein [44]. Yet, this technique was not very 
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efficient since the amino acid cleavage did not consistently occur [41]. Nowadays, tandem 
mass spectrometers such as the hybrid quadrupole/time of flight hybrid (Q-TOF), Linear 
Trap Quadrupole (LTQ)-Orbitrap and Fourier transform ion cyclotron resonance (FTIRC) 
can provide identification of phosphopeptides with high resolution and sensitivity levels 
(fmol). Still, phosphoproteomic analysis by MS encounters major limitations due to the 
phosphopeptide ion suppression [5]. To enhance their detection, phosphopeptides are 
selectively isolated or modified using immunoprecipitation, enrichment methods, chemical 
modification and alkaline phosphatase treatment prior to MS analysis [45]. 
1.3.1.1 Immunoprecipitation assay 
Phosphopeptides are present in very sm aIl amounts compared to the non-
phosphorylated peptides in a cell ex tract [42]. For this reason, immunoprecipitation 
methods using phosphospecific antibodies are required for an enhanced detection. General 
pTyr antibodies have been used for the enrichment of complex cell extracts. Antibodies 
directed against the specific amino acids sequence containing the phosphorylated residue 
(Tyr/Ser/Thr) is also used for immunoprecipitation assay. Cell lysates are initially 
incubated with phosphospecific antibodies and then the immunocomplex is collected with 
protein A-Sepharose beads. The isolated phosphoproteins are resolved by SDS-PAGE 
analysis to be further analyzed by MS [46,47]. 
OveraIl, immunoprecipitation assay has shown to achieve successful outcomes with 
anti-phosphotyrosine antibody [48]. Yet, it is still quite expensive and inconvenient to use 
antibodies for such large-scale experiments. Also, the serine and threonine antibodies 
independent of sequence context have not been used extensively due to their low specifity 
[5]. However, when antibodies are directed against a specific peptide containing Ser/Thr 
residues, the enrichment level is more significant [4]. 
Many novel phosphorylated proteins· have been identified us mg 
immunoprecipitation assay, especially with tyrosine antibody [48]. However the use of this 
method is somewhat more limited than the other enrichment procedure since it is highly 
dependent upon the efficiency of the phosphospecific antibodies. 
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1.3.1.2 Phosphopeptide enrichment methods 
Two other simi1ar approaches routine1y used for phosphoprotein enrichment are 
Ti02 and IMAC micro-columns [45, 49]. The principle of IMAC enrichment mainly 
exploits the high affinity of negatively charged phosphopeptides towards metal-chelated 
(usually Ga3+ and Fe3+) stationary phase [50]. In order to reduce non-specific binding by 
acidic si de chains of glutamic acid and aspartic acid, a pH lower than the carboxyl group 
pKa (pKa of Asp is 3.65 and pKa of Glu is 4.25) and higher than the phosphoric acid pKa 
(2.15) is used [51]. Yet, unspecific binding to acidic residues (glutamic acid & aspartic 
acid), e1ectron donors (histidine) and hydrophobic peptides is still a major pitfall [5]. To 
overcome this prob1em, Ficarro et al. [52] esterified aU carboxy1ic acid groups prior to 
enrichment, which enabled the reduction of urispecific binding by at least two orders of 
magnitude. However, reaction conditions have to be chosen correctly in order to avoid 
incomplete methylation of the carboxylic groups and side reactions. 
Recently, Larsen et al. [49] introduced a high1y selective and efficient stationary 
phase, titanium dioxide (Ti02), for phosphopeptide enrichment. A much higher enrichment 
level and recovery level was obtained by disso1ving the sample in trifluoroacetic acid 
(TF A), acetonitri1e (ACN) and 2,5-dihydroxybenzoic acid (DHB). The exact binding 
mechanism of Ti02 to the phosphate group is still unclear but Ti02 was found to have 
higher se1ectivity towards singly phosphory1ated peptides. On the other hand, it was a1so 
reported that IMAC ligands have higher affinity for multi-phosphorylated peptides [53]. 
Hence, Thingholm et al. [54] created the SIMAC technique by combining both strategies to 
improve phosphorylation sites coverage. 
Generally, IMAC and Ti02 application is performed off-line using Zip Tip or mlcro-
columns [50, 55]. To simplify the extraction procedure and minimize sample handling and 
loss, the chromatographie medium can be integrated into micro-capillary, which is 
combined to nano-LC/ESl-MS. On-line lMAC or Ti02 enrichment can be controlled by an 
interface, which is compatible to any LC and MS [56, 57]. Ti02 and lMAC enrichment is 
commonly used since it allows pre-concentrating the sample, retaining phosphopeptides, 
and removing reagents not compatible to MS [58]. Another major advantage is that Jess 
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suppression effect occurs due to enhancement of phosphopeptides and removal of non-
phosphorylated peptides. 
Even thought, immunoprecipitation, Ti02 and IMAC micro-tips significantly 
improve phosphopeptide detection by decreasing sample complexity, detection by MS still 
remains challenging due to the chemical properties of the phosphate group. In positive ion 
mode, the negatively charged phosphate group decreases the ionization efficiency of the 
peptide. AIso, since phosphate groups are very labile on phosphoserine and threonine, 
MSIMS spectrum is very poor which makes it harder for peptide sequencing [5]. ln brief, 
enrichment procedures significantly improve phosphopeptide recovery but are still limited 
for complete phosphopeptide detection. 
1.3.1.3 Chemical modification methods 
Many studies have attempted to enrich phosphopeptides by .replacing the phosphate 
group by an affinity tag. The most popular reaction, ~-elimination, exposes phosphoserines 
and phosphothreonines to strongly alkaline conditions (Li OH or Ba(OHh at pH 12) and 
yields a more reactive dehydroalanine and dehydroaminobutyrine species, respectively. The 
modified residue can act as a Michael acceptor and reacts with thiol based nucleophiles 
such as dithiothreitol (DTT) and 1,2-ethanedithiol (EDT) (Fig. 1.7) [59]. The 
phosphorylated amino acid can be identified by a mass shift resulting from the 
derivatization (-21 Da for ~-elimination and Michael addition with 2-aminoethanethiol) 
[60]. 
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Figure 1.7: (a) p-elimination reaction of phosphoserine and phosphothreonine. (b) 
Addition of a thiol group and biotin tag on phosphoserine for further 
enrichment on avidin columns [5]. 
Phosphopeptide derivatization method has greatly improved and now allows 
detection down to femtomolar range [42]. A distinct advantage of this technique over 
enrichment procedures is that removal of the phosphate group prior to mass spectrometry 
facilitates positive ion detection. Nevertheless~ this strategy still suffers from many 
drawbacks. First~ contrary to immunoprecipitation approach, chemical derivatization is not 
applicable to tyrosine phosphorylation since it would require breakage of the very stable 
aromatic ring [5]. In addition, O-linked sugar moieties may also undergo ~-elimination and 
obtain same intermediates as the phosphorylation residues [42]. Finally, incomplete 
derivatization of the phosphate moiety will result in decrease of phosphopeptide signal 
intensity after ~-elimination. 
Overall, chemical derivatization of phosphopeptide has dernonstrated to be very 
efficient for the detection of phosphopeptides. Yet, this method is dependent upon the 
extent of completion of the reaction and unwanted reactions, which might be responsible 
for the increase of complexity of the sample and phosphopeptide losses [42]. 
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1.3.1.4 A lkalin e phosphatase treatment 
Removal of the phosphate group by a phosphatase enzyme is another popular 
strategy used to avoid the ion suppression limitation of phosphopeptides in MS. The 
enriched protein digest is split in two where one half is incubated with alkaline phosphatase 
in basic conditions [61]. FoUowing MS analysis of the treated and control sample, aU the 
peptides correlated by a mass shift of 80 Da are designated as potential phosphopeptides 
[62]. If there are more than one phosphorylation site in a peptide, then mass shifts of 
multiples of -80 Da will be observed. 
One major drawback of alkaline phosphatase treatment is that the phosphorylation 
sites remain indistinguishable from other hydroxyl amino acids. To overcome this problem, 
Liao et al. used several specific proteases su ch as endoproteinase Glu-C, Asp-N and trypsin 
to degrade the phosphopeptide into smaUer fragments and locate exactly the 
phosphorylation site [61]. Also, Torres et al. addressed this issue by combining the 
advantages of IMAC, on-target dephosphorylation and hypothesis driven MALDI MS/MS 
[63]. This approach enabled the identification of four phosphate group on the C-terminus of 
the metazoan histone mRNA regulator (dSLBP), showing that alkaline phosphatase 
treatment is the method of choice to overcome the ion suppression of phosphopeptide in 
complex mixtures during MS detection. 
In short, enrichment of the phosphopeptide samples and modification of the 
phosphate group are key strategies for an enhanced phosphopeptide analysis. In addition, 
further method optimization can also be performed on the analytical separation prior to MS 
detection to obtain higher phosphopeptide coverage. 
1.3.1.5 Separation methods 
Highly complex samples can be separated ~d analyzed using high performance 
liquid chromatography (HPLC) coupled to a ESI-MS [64]. Peptides are first loaded onto a 
nano-column containing C I8 material and then eluted at a slow flow rate (200-600 nL/min) 
using a gradient ofwater and ACN. Coupling the nano-LC system to the mass spectrometer 
has been very successful for the separation of phosphopeptides and a decrease in ion 
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suppression [5]. However, since multi-phosphorylated peptides are very hydrophilic, they 
may not stick onto the hydrophobic column and will elute in the column flow-through [62]. 
Alternatively, to enhance detection of phosphorylated peptides, the sample mixture 
can initially be separated on a strong cation exchange (SCX) column followed by 
chromatographic separation into the C I8 column. Hydrophilic phosphopeptides are enriched 
in early fractions, resulting in better detection [5]. 
In summary, mass spectrometry provides a viable alternative to more traditional 
methods for phosphorylation analysis. Yet, the dual constraints of low yield of 
phosphopeptide and the mixture complexity required methods of separation and enrichment 
prior to MS analysis. Affinity enrichment procedures su ch as IMAC and Ti02 micro-
columns, chemical derivatization and anti-phosphospecific antibodies, increased the 
proportion ofphosphopeptides in a complex mixture. However, the choice ofwhich method 
is most appropriate is dependent upon the quantity of prote in available, which residue are 
expected to be phosphorylated and the degree of sample purification. Nevertheless, recent 
high-sensitive mass spectrometers have proven to significantly enhance phosphoprotein 
identification in simple and complex samples [65, 66]. 
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1.4 Mass spectrometry 
The mass spectrometer (MS) is an instrument used for determining the molecular 
mass and structure of biomolecules, drugs, proteins and oligonuc1eotides. This analytical 
tool is composed of three different sections: the ionization source, the mass analyzer and 
the detector [67]. ln proteomics-based experiments, the sample is initially digested by 
trypsin and th en the peptide mixture can undergo chromatographic separation or is directly 
introduced into the MS [68]. Upon ionization in the source, the ions travel into the analyzer 
where they will be separated according to their mass (m) -to-charge (z) ratio (m/z). The 
signal collected from aIl these ions is transformed to generate m/z spectrum [67]. Lastly, the 
raw chromatograms are processed through specialized softwares that further enable the 
profiling and identification of the proteins in the sample (Fig. 1.8) [69]. 
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Sorne instruments contain two or more analyzers, which can be used for structural 
and sequencing studies [67]. Several different types of MS are available commercially such 
as the triple quadrupole, hybrid triple quadrupole/linear ion trap (Q-TRAP), matrix assisted 
laser desorption ionization-time of flight (MALDI-TOF), hybrid quadrupole/time of flight 
hybrid (Q-TOF), Fourier transform ion cyclotron resonance (FTICR) and the linear trap 
quadrupole (L TQ)-Orbitrap. Ali of these instruments offer different applications in the field 
of MS. 
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1.4.1 Electrospray ionization 
The most common ionization method used for biological applications is the 
electrospray ionization (ESI). This technique was first introduced by Fenn in 1984 [64]. 
The analysis can be perfonned in positive or negative ion mode depending on the proton 
affinity of the sam pie. ESI can be coupled to a HPLC or a CE since the analyte is converted 
from a liquid to a gaseous phase [70]. 
The atmospheric pressure interface of an ESI source is composed of a capillary where the 
sample solution is exposed to very high voltage (3-5 kY) applied to the tip. A stream of 
nebulising gas (nitrogen) can also be present around the capillary to facilitate the 
nebulisation of the analytes [71]. As the charged liquid first exits the emitter's tip, a cone 
shape, known as a Taylor cone, briefly fonns (Fig. 1.9). With the assistance of the drying 
gas (nitrogen), droplets decrease in size by solvent evaporation which forces the charges in 
the molecules closer together [71]. A Coulombic explosion occurs when there are too many 
charges being confined within a too small are a and start repelling each other (Rayleigh 
limit), causing the droplets to divide into two smaller droplets. This process repeats itself 
until the solvent is completely evaporated and the droplets have split up to become one 
single charged molecule (Fig. 1.9) [67]. This ionization process is very fast and occurs 
within milliseconds. 
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A new method named nano-eJectrospray ionization uses flow rate of sampJe 
injection of 20-40 nL/min and minimizes Joss of anaJyte [71]. The decrease in drop Jet size 
and inner diameter of the emitter enabled an ionization efficiency of two orders of 
magnitude greater than the conventional ESI [64]. Hence important parameters that 
influence the electrospray stability are the voltage applied, the flow rate and the emitter 
size. Overall, ESI provides a continuous stream of multiply charged ions that can be 
introduced in a multitude of mass analyzers. 
1.4.2 L TQ-Orbitrap mass spectrometer 
As technology progresses, more important advancements take place in the mass 
spectrometry field. For instance, several years ago, detection of about few hundreds 
phosphopeptides in a complex cell extract was considered very high for mass spectrometry 
analysis [52]. Recently, a new and very powerful mass spectrometer, the LTQ-ürbitrap, 
enabled the identification of almost 1000 phosphopeptides for large-scale 
phosphoproteomic analysis [66]. This observation shows that the extent to which biological 
information can be gained is completely dependent upon the analytical performance of the 
MS. The Linear Trap Quadrupole (LTQ)-Orbitrap recently invented by Makarov is one of 
the most efficient hybrid mass analyzer. 
The orbitrap mass analyzer is an electrostatic trap containing an inner and outer 
electrode. Ions are injected tangentially in the trap and move in complex spiral patterns aIl 
around the inner electrode [72]. A Fourier transform performs the mass analysis based on 
image current detection of oscillation frequencies [73]. For this reason, the FTICR and 
orbitrap have similar level of mass accuracy and resolution [5]. The orbitrap has a mass 
accuracy below 2 ppm, a high dynamic range (~5000) and a maximum resolving power of 
100,000 that can be reached in 1.6 sec of analysis and 400 m/z [73, 74]. Even though the 
orbitrap is able to perform MS/MS analysis, a lower sensitivity is observed due to the loss 
of ions in the C-trap. Hence, it is more practical to link the orbitrap to another mass 
analyzer, the linear ion trap, which will perform MSIMS analysis with much higher 
sensitivity. This hybrid ofmass analyzers is referred to as Linear Trap Quadrupole (LTQ)-
Orbitrap (Fig LlO). 
Autosamplcr 
& HPLC LTQ Orbitrap 
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Figure 1.10: L TQ-Orbitrap hybrid mass spectrometer (Thermo Electron) cou pied to a 
nano-flow Le (Eksigent) with a Spark-Holland autosampler (Thermo 
Electron). 
The L TQ-Orbitrap is composed of three main elements; the linear quadrupole ion 
trap, the C-trap and the orbitrap (Fig. 1.11 ). lnitially, the ions are accumulated into the 
linear quadrupole ion trap and then transferred into the C-shaped storage trap (C-trap) . The 
C-trap is used to store and collisionally cool ions, which are subsequently pu1sed into the 
orbitrap [74] . 
ESI source Linear ion trap 
l 
L 
C-trap 
--
--
--===~ -==; 
- - -.!-.. -= 
Orbitrap 
Figure 1.11: A schematic representation of the LTQ-Orbitrap mass spectrometer [73]. 
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The MS and MS/MS analysis can be recorded independently or in tandem with both 
mass analyzers (linear quadrupole ion trap and orbitrap) according to the experimental 
requirements. The most popular approach used for peptide identification is to combine the 
fast MSn capabilities of the linear ion trap with the high resolution and mass accuracy of the 
orbitrap [73]. For the tandem MS analysis, the ion trap stores and stabilizes ions by 
applying a RF voltage. Maximum resolution and sensitivity is achieved by cooling down 
the ions with a damping gas. By increasing the RF voltage, ions are destabilized and ejected 
from the trap. As a result, only one peptide is kept where bond cleavage occurs upon 
vibrational excitation [67]. In a total time of 1 sec, the duty cycle of the LTQ-Orbitrap 
consists of 3-5 MS/MS analysis for one survey scan [73]. 
In summary, this higher number of acquired MSIMS spectrum considerably 
enhances the overall number of peptide identification. Aiso the faise positive rate of high-
throughput peptide analysis is significantly smaller due to the instrument's high mass 
accuracy. 
1.4.3 Tandem MS 
Tandem MS is mainly applicable for small drug molecules and peptides. MS/MS 
spectrum offers structural information which can be pieced together to generate the 
complete peptide sequence. The process consists of isolating a particular ion, which 
subsequently coUides with neutral gas atoms (nitrogen, argon or helium) in the collision 
cell. Ions will absorb the kinetic energy which induces breakage of peptide bonds to form 
product ions [67]. Ali these fragmented ions are separated according to their m/z by the 
mass analyzer and finaUy provide a fingerprint pattern of the precursor ion under 
investigation [75]. Throughout one survey scan of a chromatographie run, the most 
abundant ion at a given time is kept in the trap and is further fragmented to obtain the 
MS/MS scan [69]. The success of de novo sequence interpretation largely depends upon the 
mass accuracy and resolution of the instrument. 
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Three different peptide bonds (NH-CH, CH-CO and CO-NH bond) can be 
fragmented depending on the MS conditions. Upon bond breakage, two fragments are 
created where one is charged and the other neutral depending on the chemistry and proton 
affinity of the two species [67]. In ail, there are six different possible fragment ions; a, b 
and c ions when the charge is retained on the N-terminus and x, y and z ions for C-terminal 
charged molecules. Since it requîres less energy, the most common fragmentation pattern is 
the b and y type ions (Fig. 1.12) [75]. 
b--b 
1 
+ 
Figure 1.12: Peptide fragmentation in low collisional energy illustrating b and y ions 
[69). 
During tandem mass spectrometry, the phosphate moiety of phosphopeptides is 
predominantly lost and usually serves as a signature for phosphopeptides. Since the P~ 
bond is much weaker than a peptide bond for Serrrhr phosphorylated precursor, a satellite 
ion, [M+H-98t, is generated du ring fragmentation [76]. The unsaturated form of the serine 
(69.03 Da) and threonine (83.05 Da) will indicate the presence of a phosphate moiety in a 
MS/MS spectrum [71]. On the other hand, the phosphate group on tyrosine phosphorylated 
peptides usually remains attached to the side chain during MSIMS analysis due to 
tyrosine's stable ring structure [77]. Hence, the phosphorylated tyrosine can be identified 
with a mass of243.18 Da (163.18 + 80 Da) on the MSIMS spectrum. 
The MSIMS spectrum can be interpreted manually or through different specialized 
algorithms (Mascot, Sequest and ProteinProspector) that try to match the fragments ions to 
theoretical values expected from a large protein database [69]. 
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1.4.4 Data processing 
1.4.4.1 MS/MS ion search using Mascot 
In proteomics studies, Mascot from Matrix Science 
(http://www.matrixscience.comQ is a very popular database engine used to identify proteins 
from MSIMS spectrum and protein databases. Mascot is a useful tool for the interpretation 
of Jess informative MS/MS spectrum or complex protein mixtures [69]. Prior to the Mascot 
search, necessary information about the MS experiment needs to be added in the Mascot 
search engine page in order to minimize the [aise positive rate especially for the large scale 
proteomic analysis (Fig. 1.13). 
MASCOT MS/MS Ions Search 
Your n~me 
Search title 
D~t~b~se MSDB 
T axonomy Ali entries 
Enzyme TrYPsin 
Fixed Biotin (Ki 
modific~tions Biotln (N-term) 
Carbamyi (K) 
Carbamyl (N-term) 
Qu~ntitèltion None 
Peptide toI. ± 0.05 Da .... # "e 0 .-
Peptide charge 1 +, 2+ and 3+ .... 
D~t~ file 
O~t~ torm~t Mascot Q8n8nc .... 
-Instrument ESI-TRAP T 
Decoy 
Em~il 
-
.... 
Allo,"" up to 1 .. mlssed cleavaQes 
V~ri~ble OXldatlon (HW) 
modific~tion5 Oxidation (M) 
Proplonamlde (C) 
MS/MS toI. ± 0.5 Da .... 
Monoisotopic ... Averl!lQe 
Precursor mil 
Error toler~nt 
Report top AUTO .... hits 
Reset Funn 
-
COPVPlght ç:, 2'J08 M,;tm~ ';':I4tflCa .. '.:d A.II P.II3"'~ R.~C"lIad 
Figure l.13: Mascot search engine page showing aIl parameters for a MS/MS ion 
search. 
The general approach consists of first downloading the file containing ail MS/MS 
spectra (fragment ions with their intensity, m/z and RT) to Mascot. Then, the most suitable 
database (MS DB, IPI, SwissProt and NCBInr) and species are determined according to the 
proteins characteristics. The sample preparation is taken into consideration by choosing the 
enzyme responsible for the digestion, the number of allowed missed cleavage sites and the 
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fixed and variable modifications. Finally, the mass accuracy of the mass analyzer for the 
MS and MSIMS analysis is indicated to set a mass tolerance range for confident peptide 
detection. As a result, a list containing the peptide's sequence, matching protein, m/z, RT, z 
and Mascot score is generated. 
OveralI, Mascot is a great tool for quick and high-throughput protein identification. 
To obtain a complete analysis of the proteomic study, Mascot identification must be 
combined with a quantification method. 
1.4.4.2 Mass Sense & peptide clustering 
For the quantification analysis of complex protein mixtures, different types of 
methods are available using relative or absolute measurements and label-free or derivatized 
prote in mixtures. Mass Sense and peptide clustering are in-house label-free bioinformatics 
softwares developed by Jaitly et al. [78]. 
From raw MS files, Mass Sense software computes with high confidence a contour 
map with four different coordinates; m/z value, retention time (RT), charge (z) and 
abundance (Fig. 1.14). From the manual validation of this software, the false positive and 
false negative rate corresponded to 4.6 % and 7.4 %, respectively [78]. A seore value is 
attributed to each identified peptide ion reflecting the correlation between observed and 
expected abundanee ratio of isotopie ions. ln addition, an excel list is generated displaying 
the m/z value, z, RT, intensity and Mass Sense score for each peptide. Hence, Mass Sense is 
capable to display statisticaUy significant fold-change in abundance aeross cellular 
replicates and conditions. 
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Figure 1.14: Contour plot generated by Mass Sense. Peptide abundance is represented by 
a colour gradient from yellow (most abundant) to black (Ieast abundant) . 
Peptide's charge is illustrated by a symbol described in the legend. 
The Peptide Cluster Miner software enables the comparison of peptide intensities of 
several replicates or samples in different conditions. Peptides with similar m/z, RT and 
charge within the tolerance range, are clustered together. As a result, a list displaying ail the 
peptides with their corresponding abundance in each different condition is generated. ln a 
similar fashion, the clustered peptides can be aligned to the peptide identification list from 
the Mascot search. Hence, this tool allows the generation of expression profiles for the 
better understanding of identified peptide abundance change across different conditions. 
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2. Combined enzymatic and data mining approaches for 
comprehensive phosphoproteome analyses; application to cell 
signaling events of interferon-y stimulated macrophages 
Marcantonio, M., Trost, M., Courcelles, M., Desjardins, M., and Thibault, P. (2008) 
Molecular & Cellular Proteomics, 7: 645-660. 
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2.1 Abstract 
Protein phosphorylation is a central cell signaling event that underlies a broad 
spectrum of key physiological processes. Advances in affinity chromatography and mass 
spectrometry are now providing the ability to. identify and quantitate thousands of 
phosphorylation sites simultaneously. Comprehensive phosphoproteome analyses still 
present sizable analytical challenges in view of suppression effects and the variable quality 
of MS/MS spectra. This work presents an integrated enzymatic and data mining approach 
enabling the comprehensive detection of native and putative phosphopeptides following 
alkaline phosphata se digestion of titanium dioxide (Ti02)-enriched cell extracts. The 
correlation of retention times of more than 750 phospho- and dephosphopeptide pairs from 
1774 macrophage cell extracts indicated that removal of the phosphate groups can impart a 
gain or a loss in hydrophobicity that is partly explained by the formation of salt bridge with 
proximal amino groups. Dephosphorylation also led to an average 2-fold increase in MS 
sensitivity which facilitated peptide sequencing. More importantly, alkaliné phosphatase 
digestion enhanced the overall population of putative phosphopeptides from Ti02-enriched 
cell extracts providing a unique approach to profile multi-phosphorylated cognates that 
would have remained otherwise undetected. The application of this approach is 
demonstrated for differential phosphoproteome analyses of mouse macrophages exposed to 
IFN-y for 5 min. Ti02 enrichment enabled the identification of 1143 phosphopeptides from 
/ 
432 different proteins of which 125 phosphopeptides showed a 2-fold change upon IFN-
y exposure. The use of alkaline phosphatase nearly doubled the number of putative 
phosphopeptides assignments leading to the observation of key IFN-y signaling events 
involved in vesicle trafficking, production of reactive oxygen species and mRNA 
translation. 
32 
2.2 Introduction 
In biological systems, signal transduction pathways are primarily guided through 
post-translational modifications (PTMs) of proteins to transmit information from 
extracellular stimuli into the cytoplasm and nuclei of cells for changes in cytoskeletal 
structure, vesicle transport and gene transcription [37]. Prote in phosphorylation is the most 
abundant reversible PTM and a major regulator of prote in activity or stability. About one 
third of proteins encoded by the human genome are assumed to be phosphorylated during 
their life cycle [79]. Phosphorylation can occur on several residues, but it is mostly found 
on hydroxyamino acids such as serine, threonine and tyrosine residues with a ratio of about 
89: 1 0: 1 [80]. Because protein phosphorylation ho Ids a central role in signaling networks, 
considerable effort is attributed to the development of methods for phosphoprotein 
characterization. Highly sensitive detection techniques are required because 
phosphoproteins represent only a small proportion of any given cell ex tracts (typically ~ 1-
2%) [42]. Most conventional methods su ch as two-dimensional-gels, 32p radioactive 
labeling and Western blotting have limited features, which do not enable them to 
comprehensively profile phosphoproteome change or identify the exact phosphorylation 
site. 
To overcome this challenging task, mass spectrometry has emerged as a sensitive, 
rapid and effective tool for accurate and specific localization of post-translational 
modifications such as protein phosphorylation. Nevertheless the negatively charged 
phosphate group on phosphopeptides renders their MS analysis more difficult than their 
non-phosphorylated counterpart. For instance, MSIMS spectra of phosphopeptides are less 
interpretable than their non-phosphorylated counterpart due to the abundant fragment ion 
corresponding to the 10ss of the labile phosphate group (80 or 98 Da). Also database search 
engines are better adapted to the correlation of linear sequences compared to peptides with 
labile functionalities. In positive ion mode, this difficulty is compounded with the under-
represented population of phosphopeptide abundance due to suppression effects in an 
overwhelming large population of non-phosphorylated peptides [79]. The coupling of the 
nano-Le system to the mass spectrometer has been very successful for the separation of 
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phosphopeptides and led to a decrease in ion suppression [5]. However, because multi-
phosphorylated peptides are very hydrophilic, they may not be retained on the hydrophobic 
colurnn and will elute in the colurnn flow-through [62]. On the other hand, Steen et al. [81] 
used a small set of synthetic phosphopeptides. and their dephosphorylated cognate to 
indicate that the challenge in phosphopeptide identification is primarily due to the low 
abundance of this PTM rather than their lower ionization efficiency. 
Phosphopeptide enrichment is an indispensable step for the analysis of large-scale 
phosphoproteomics to reduce sample complexity and to enhance their detection. 
Immobilized Metal Ion Chromatography (IMAC) using Fe(III) or Ga(lII) and titanium 
dioxide (Ti02) micro-colurnns are most commonly used as selective isolation method of 
phosphopeptides [42]. These techniques allow pre-concentrating the sample, retaining 
phosphopeptides, and removing salts and detergents not compatible to MS [58]. Yet one 
major pitfall is the unspecific binding of acidic residues (glutamic acid and aspartic acid), 
electron donors (histidine) and hydrophobic peptides [5]. To overcome this problem, 
Ficarro et al. [52] converted aIl carboxylic groups to the corresponding methyl esters using 
HCl-saturated, dried methanol before IMAC enrichment. ln addition, Larsen et al. [53] 
demonstrated that 2,5-dihydroxybenzoic acid (DHB) significantly improved 
phosphopeptide recovery by selectively displacing acidic peptides from the Ti02 stationary 
phase. However, depending on the column material, the phosphopeptide populations 
enriched seem to differ and the suppression effect of phosphopeptides is still evident in 
enriched complex samples [82]. This raises the question if many more phosphopeptides are 
still not detected due to their weak ionization efficiency in positive ion mode. Several teams 
have tried to approach this issue by chemically modifying the phosphate group by ~­
eliminationIMichael addition reactions, which will enhance the level of detected 
phosphopeptides [59, 83]. Yet, this method is dependent upon the reaction yield and 
unwanted side-reactions and is only applicable to Ser and Thr residues. The study of 
tyrosine phosphorylation is mainly achieved by immunoprecipitation with anti-pTyr 
monoclonal antibodies [84]. However, large-scale analysis of phosphotyrosine using 
specific antibodies commercially available can be relatively expensive and would not 
provide any information on serine and threonine phosphorylation. Another strategy adapted 
recently identified phosphopeptides in a sample using alkaline phosphatase (AP) treatment 
34 
applicable to aIl hydroxyamino acids, even tyrosine residues [63, 85, 86]. The major 
drawback from AP approach is the information of the phosphorylation site on the peptide is 
lost. 
In the present study, we de scribe a combined enzymatic and data mining approach 
to comprehensively identify trace-Ievel phosphopeptides from cytosolic protein extracts of 
macrophage ceIls. This strategy is further demonstrated for differential phosphoproteome 
analyses of macrophages from control and IFN-y challenge experiments. Several 
phosphoproteins involved in vesicle trafficking, reactive oxygen species (ROS) production 
and mRNA translation were identified as significantly over or under-expressed upon early 
macrophage activation. The collection of a large number of phosphopeptides containing 
even multi-phosphorylated species treated with AP enabled a more extensive study on the 
comparison between phosphopeptides and their dephosphorylated cognate using in-house 
bioinformatic tools. The higher intensity and the appearance of new putative 
phosphorylated peptides confirmed the reduced ionization efficiency of phosphopeptides in 
positive ion mode. The correlation of retenti on time between phosphopeptides and their 
dephosphorylated counterparts also provided a meaningful approach to determine changes 
in hydrophobicity upon dephosphorylation. 
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2.3 Experimental Procedures 
2.3.1 Materials 
Acetonitrile (ACN) was purchased from Fisher Scientific (Whitby, ON, Canada). 
Formic acid (FA), ammonium acetate and ammonium bicarbonate were obtained from EM 
Science (Mississauga, ON, Canada). Ammonium hydroxide, trifluoroacetic acid (TF A), 
acetic anhydride, a-casein, DTT, iodoacetamide, imidazole, sucrose, urea and acetic acid 
were purchased from Sigma-Aldrich. Tyr(P03H2)4-Angiotensin II Human was obtained 
from Calbiochem. BCA prote in assay, immobilized TPCK trypsin, bond breaker tris(2-
carboxyethyl)phosphine (TCEP) solution and phosphopeptide isolation kit One SwelIGel® 
gallium disc/column were purchased from Pierce. Fetal bovine serum (FBS), penicillin-
streptomycin,L-glutamine and DME/High glucose Dulbecco's modified eagle's medium 
were purchased from HyClone (Perbio, Nalgene). 
2.3.2 Preparation of standard proteins 
A solution of eight reduced and iodoacetamide-alkylated prote in standards (40 
fmol/IlL each) was prepared from individual digests of bovine serum albumin, rabbit 
phosphorylase b, yeast alcohol dehydrogenase, bovine deoxy-ribonuc1ease, horseradish 
peroxidase CIA, bovine glyceraldehyde 3P dehydrogenase, Escherichia coli ~­
galactosidase, and bovine carboxypeptidase A (Michrom Bioresources, Auburn, CA). a-
Casein was digested with immobilized trypsin in 50 mM ammonium bicarbonate overnight 
at 37°C and then evaporated to dryness. 
2.3.3 CeU cultures 
1774 (murine macrophage ce Ils) were cultured in Dulbecco's modified Eagle's 
medium (DMEM), pH 7.4, supplemented with 10% heat inactivated fetal bovine serum 
(FBS), 2 mM L-glutamine and antibiotics (100 mg/mL penicillin & 100 mg/mL 
streptomycin), at 37°C in 5% CO2 atmosphere. Cells were plated in 100 mm Petri dishes at 
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a density of 20 million cells per dish corresponding to approximately 330 Ilg of cytosolic 
prote in extracts. For IFN-y challenge experiments, 1774 cell cultures were incubated for 5 
min with mouse interferon-y (PBL Biomedical Laboratories) (100 U/mL). 
2.3.4 Protein extraction and immobilized trypsin digestion 
r 
Cells were washed with IX PBS to remove culture media. Cells were resuspended 
in 8.5% sucrose (w/w)/3 mM imidazole and broken with a metal douncer homogenizer. 
Nuc1ei were removed by centrifugation at 860 g for 15 min. Cell lysates were 
ultracentrifuged at 150,000 g for 30 min to discard membrane proteins. Cytosolic proteins 
in the supematant were precipitated by acetone. Proteins were resuspended in 1 % SDS/50 
mM ammonium bicarbonate for phosphopeptide Ti02 enrichment or in 8 M urea/50 mM 
ammonium bicarbonate for IMAC Ga +3 micro-colurnns phosphopeptide enrichment. 
Proteins were reduced in 0.5 mM TCEP for 20 min at 37°C and th en alkylated in 50 mM 
iodoacetamide for 20 min at 37°C. 50 mM DTT was added to the prote in solution to react 
with excess iodoacetamide. Total protein amount was quantitated by BCA protein assay. 
Proteins were digested in 1 M urea or 0.1 % SDS, 50 mM ammonium bicarbonate with 
immobilized TPCK trypsin ovemight at 37 OC and high agitation speed (250 ilL of trypsin 
per mg of sample). The digest mixture was acidified with trifluoroacetic acid (TF A) and 
then evaporated to dryness. 
2.3.5Phosphopeptide isolation 
Two different affinity-based methods (lMAC Ga3+ and Ti02 micro-colurnns) for 
phosphopeptide enrichment were used in this study. For the IMAC isolation protocol, 1774 
cell digests were resuspended in 5% FA and incubated for 20 min at roOrD temperature in 
SwellGel Ga(lU) disc/colurnn. IMAC beads were washed with 0.1% FA (two times), 30% 
ACN/0.07% FA (two times), and finally water. Lastly, phosphorylated peptides were eluted 
with 2 x 25 ilL of 0.1 % ammonium acetate pH 9.6. For the Ti02 procedure, sample loading, 
washing and elution were performed by applying gas pressure from a nitrogen tank to the 
Ti02 micro-tips. Each micro-column was used once to avoid contamination. In-house Ti02 
(5 Ilm, GL Sciences, Japan) micro-colurnns were equilibrated with 10 ilL 3% TF A, 70% 
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ACN. The digest mixture was redissolved in 350 mg/mL 2,5-dihydroxybenzoic acid (DHB) 
(Aldrich), 3% TFA, 70% ACN. Unless otherwise indicated, 250 Jlg (50 JlL) of protein 
digests (equivalent to 15 x 106 cells) were loaded onto a l.25 mg Ti02 micro-column. The 
column was washed first with 10 JlL of 350 mg/mL DHB, 3% TF A, 70% ACN and then 2 
times with 30 ilL of 3% TF A, 70% ACN. The bound phosphopeptides were eluted with 30 
JlL (or 50 JlL for the IMAC comparison experiment) of 1 % ammonium hydroxide pH 10. 
The e1uate was acidified with 1 ilL of TF A and 20 ilL of the enriched sample was injected 
on the L TQ-Orbitrap mass spectrometer. Unless otherwise indicated, samples were 
prepared in triplicate for each condition under study. 
2.3.6 Alkaline phosphatase treatment 
The reaction consisted of incubating half of the sample for 2 h at 37°C at high 
agitation speed with 20 Units of calf intestine AP (New England BioLabs) per 175 Jlg of 
protein in basic conditions. For the analysis of standard proteins, 175 Jlg of digested u-
casein and 10 pmol of eight known non-phosphorylated proteins with 0.1 mM 
phenylmethyl sulphonyl fluoride (PMSF) were resuspended in 50 mM ammonium 
bicarbonate and then treated with 20 Units of AP. For the Ti02-enriched 1774 
phosphopeptides, half of the eluate {l5 ilL) was treated with 20 Units (2 ilL) of AP and 2 
JlL of 1 % ammonium hydroxide pH 10 was added to the other half of Ti02-eluate. After 
dephosphorylation, treated and non-treated samples were acidified with 1 ilL of TF A and 
injected on the LTQ-Orbitrap mass spectrometer. For N-acetylation of Ti02 enriched u-
casein phosphopeptides, dried samples were initially resuspended in 40 ilL of 50mM 
ammonium bicarbonate and th en derivatized with 100 JlL of acetylation reagent (anhydrous 
MeOH: acetic anhydride 3:1). After a 30 min derivatization period at room temperature, 
samples were evaporated on a SpeedVac concentrator prior to AP digestion. 
2.3.7 Le-MS/MS analysis 
LC-MSIMS analyses were perforrned on a LTQ-Orbitrap hybrid mass spectrometer 
(Therrno Electron, San Jose, CA) coupled to a nano-flow LC (Eksigent, Dublin) with a 
Spark-Holland autosampler (Therrno Electron, San Jose, CA). The analytical column {l0 
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cm length, i.d. 150 J.lm) and trap column (4 mm length, i.d. 360 J.lm) were packed in-house 
with C18 Jupiter (3 J.lm & 300 Â) material (Nalgene, Phenomenex, Torrance, CA). Peptides 
were eluted from the reverse phase column into the mass spectrometer using a gradient 
from 2% to 25% B over 63 min followed by a gradient from 25% to 40% over 15 min with 
a flow rate of 600 nL/min (A: 0.2% FA in water, B: 0.2% FA in ACN). MS spectra were 
acquired in FTMS positive ion mode for 1 sec from mlz 400 to mlz 1600 with a resolution 
of 60,000. Mass calibration used Calmix (caffeine, MRFA, and ultramark) and typically 
provided mass accuracy within 15 ppm on average for all nanoLC-MSIMS experiments 
without using a lock mass. The nanoelectrospray voltage and MS/MS fragmentation 
amplifier voltage were set to 1.6 V and 1.3 V, respectively. The mass spectrometer operated 
in data-dependent mode where a survey scan is initiated in full scan at high mass accuracy 
in the Orbitrap followed by tandem MS in the linear ion trap of the 3 most abundant 
precursor ions. A dynamic exclusion window was applied to prevent MS/MS analysis of 
. previous selected ions 80 sec after its acquisition. Only multiply charged ions with intensity 
above 10,000 counts were selected for MS/MS sequencing. Tandem MS analysis operated 
in a total time of 1 sec from one third of precursor ion mlz to mlz 2000. 
2.3.8 Database searching with mass spectrometry data 
Data were analysed with Xcalibur (version 2.0 SRI) software and peak lists were 
generated using Mascot distiller (version 2.1.1, Matrix Science, London, UK) software and 
LCQ-'p1us _zoom script. Database searches were performed against an IPI mouse database 
containing 52,326 entries [87] (version 3.24, released November 2006) using Mascot 
(version 2.1, Matrix Science) selecting mouse species for 1774 cell extract analysis. Data of 
a-casein and eight non-phosphorylated proteins were searched against in-house compiled 
database where the sequences were taken from UniProtKB/Swiss-Prot database (release 
9.0, October 31 2006). Parent ion and fragment ion mass tolerances were both set at +/-
0.05 and 0.5 Da, respectively. One missed c1eavage was allowed for trypsin digestion and 
phosphorylation (STY), oxidation (M), deamidation (NQ) and carbamidomethylation (Cys) 
were selected as variable modifications. AlI protein identifications and IPI entry numbers 
were reported for peptide sequences matching more than one protein entry. A Mascot 
search against a concatenated targetldecoy database consisting of a combined forward and 
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reverse verSIOn of the IPI mouse database was perforrned to establish a cutoff score 
threshold for a false-positive rate of less than 2% (p < 0.02) [88]. The location of the 
phosphorylation site was based on the highest ranking assignrnent with a Mascot score ~5 
to the next leading candidate. AU possible phosphorylation sites were reported if the 
Mascot scores could not provide sufficient discrimination amongst the leading candidates. 
2.3.9 Peptide detection and c1ustering 
Raw data files (.raw) generated from the LTQ-Orbitrap acquisition software were 
converted into text files representing aU ions according to their corresponding m/z values, 
retention time, peak widths, intensity and charge state using in-house peptide detection 
software [78]. Intensity values above a user-defined intensity threshold CI 0,000 counts) 
were considered. Segmentation analyses were perforrned across different samp1e sets using 
hierarchical c1ustering with criteria based on their respective m/z, charge and time within 
user-defined tolerance (±0.05 mlz and ±l min). Norrnalization of retenti on time is then 
perforrned on the initial peptide c1uster list using a dynamic and nonlinear correction. A 
moving-average time-window interpolation scheme is used to compute the time shifts for 
each peptide across the different data sets. For replicate Le-MS injections, this alignrnent 
confines the retention time distribution to less than ± 0.1 min « 0.3% relative S.D.) on 
average. The generated unique list of peptide c1usters allowed the direct comparison of 
peptide abundance between samples in different conditions to identify those showing 
reproducible and statistically meaningful changes in abundance. Aiso peptide c1usters were 
aligned with phosphopeptide identification file from Mascot according to set m/z and 
retention time tolerance (±0.05 mlz and ±l min). In addition, to compare the retenti on time 
and abundance of phosphopeptides and their dephosphorylated counterpart, specifie 
algorithms were deve10ped to c1uster peptide ions from control and phosphatase-treated 
samples that displayed changes in retenti on time up to 5 min and precise mass shifts for one 
or multiple phosphate groups (HP03: 79.9663 Da). 
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2.4 Results 
2.4.1 Evaluation of phosphopeptide enrichment methods 
Large-scale proteomics analyses of phosphopeptides have been very difficult due to 
the strong signal suppression taking place in the presence of a high number of non-
phosphorylated peptides [79]. Phosphate group affinity media such as titanium dioxide 
(Ti02) and metal ions (Ga3+ and Fe3+) are the most analyzed and optimized enrichment 
methods for the isolation of phosphopeptides [45, 82]. In this study, the phosphopeptide 
enrichment performance of Ti02 micro-tips introduced by Larsen et al. [53] was compared 
with the phosphopeptide isolation kit One SwellGel Ga(lU) disc/colurnn from Pierce. In 
total, 679 peptides were identified with a Mascot score above 25 from the Ti02-enriched 
sample where 76.9% corresponded to phosphopeptides. On the other hand, Ga3+ metal ions 
extraction method obtained a much lower phosphopeptide enrichment level (37.0%) from 
the 451 identified peptides (Fig. 2.1, and Table 2.1). 
a) IMAC b) IMAC 
Phosphopeptides Non-phosphopeptides 
Figure 2.1: Comparison of lMAC (Ga3") and Ti02 enrichment procedures. Venn 
diagrams showing the number of unique and common 1774 (a) 
phosphopeptides and (b) non-phosphorylated peptides using both isolation 
methods. 
Table 2.1: Comparison of Ti02 and lMAC (Ga3) phosphopeptide enrichment 
methods using 250 eg J774 cell extract 
Total (IMAC) 
Total (Ti02) 
Common 
Unique (IMAC) 
Unique (Ti02) 
Phosphopeptides 
167 
522 
94 
73 
428 
Non-phosphopeptides 
284 
157 
95 
189 
62 
Total 
451 
679 
Enrichment level 
37.0% 
76.9% 
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A large divergence in selectivity towards phosphopeptides and non-phosphorylated 
peptides was noted using different affinity media and enrichment protocols. Interestingly, 
70% and 18% of phosphopeptides isolated by the IMAC and Ti02 technique corresponded 
to multi-phosphorylated peptides, respectively. This comparison suggested that Ti02 micro-
columns are less likely to retain peptides with multiple phosphate groups but offer a 
stronger affinity towards singly phosphopeptides. Since Ti02 micro-tips offered a mu ch 
higher number and proportion of phosphopeptides than the SwellGel Ga(lII) discs from 
Pierce, further experiments requiring enrichment of phosphopeptides were performed using 
Ti02 micro-tips. 
Subsequently, the overall characteristics of Ti02 beads were evaluated to ensure 
most optimal phosphopeptide enrichment of 1774 macrophage celI extract. First, a column 
capacity assay was performed in triplicate using five different loading amounts of 1774 
tryptic digest (63, 125, 250, 500, 1000 Ilg). The same level of a-casein (0.4 ng/Ilg celI 
extract) and 1 pmol of Tyr(P03H2t-Angiotensin Il were spiked for different sample 
loading of cell extracts. Upon LC-MSIMS analysis, more than 80% of assigned peptides 
corresponded to phosphopeptides except for the 63 Ilg injection of cell extract. Also, the 
highest number of identified phosphopeptides (Mascot score >25) was obtained when 
loading 250 J.lg cell extract onto Ti02 micro-tips. Similarly, expression profiling analysis 
indicated that 250 Ilg of cell extract provided the most abundant level of phosphopeptides. 
Figure 2.3a shows that the recovery level of a-casein phosphopeptides such as 
VPQLElVPNpSAEER and TVDMEpSTEVFTK, reached a maximum at 250 J.lg and then 
decreased for larger amount of celI extracts. The same trend was also observed for 
phosphopeptides from 1774 digest (Fig. 2.2a). ln contrast, non-phosphorylated peptides 
showed a different behavior on Ti02 beads whereby the number of unspecific binding 
significantly increased ab ove 250 Ilg of cell extract (Fig. 2.2b). The second standard, 
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Tyr(P03H2t-Angiotensin II (DRVpYIHPF), which was equally loaded on each micro-
column, was less retained by Ti02 beads as more prote in digest was loaded onto the micro-
tip (Fig. 2.3a). At 250 Ilg of 1774 cell extract, only -35% of Tyr(P03H2t-Angiotensin II 
was lost whereas -65% was not retained by the Ti02 beads when twice the amounts of cell 
extract was loaded. Hence, aIl experiments performed in this study used 250 Ilg of cell 
extract for 1.25 mg Ti02 micro-tips since most phosphopeptides are retained on the column 
and higher enrichment level is obtained. 
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Figure 2.2: Capacity test of 1.25 mg Ti02 micro-tips using spiked phosphopeptides 
from J774 cytosolic cell extract (n=3). Intensity of various 1774 (a) 
phosphopeptides and (b) non-phosphorylated peptides identified at different 
loading amounts of J774 cell extract onto the micro-column. 
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Figure 2.3: Loading capacity and linear dynamic range of TiOz enrichment procedure. 
(a) Capacity test of 1.25 mg Ti02 micro-tips using spiked phosphopeptides from 1774 
cytosolic ceU extract (n=3). Intensity of a-casein (m1z 830.92+ VPQLEIVPNpSAEER) 
and [Tyr(P03H2)4]-Angiotensin II (m1z 563.72+ DRVpYIHPF) phosphopeptide spiked 
into 1774 protein digest versus various amounts of 1774 ceU extract loaded on the 
micro-tips. Optimalloading amount of 1774 protein digest was 250 Ilg. (b) Plot of (log-
log) observed versus calculated fold change of Ti02-enriched a-case in amounts spiked 
into a 250 Ilg 1774 protein digest (n=3). A linear relation was observed for spiked a-
casein phosphopeptides (mlz 830.92+ VPQLEIVPNpSAEER, m1z 972.42+ 
DIGpSEpSTEDQAMEDIK+oxidation, mlz 770.32+ EQLpSTpSEENSKK, mlz 741.82+ 
TVDMEpSTEVFTK +oxidation, mlz 976.52+ YKVPQLEIVPNpSAEER) with an 
average RSD of 34.2%. Average observed fold change for each 1774 enriched 
phosphopeptides (mlz 633.82+ RAGDVLEDpSPK, mlz 644.32+ KAApSPpSPQSVR, 
m1z 645.82+ ApSDPGLPAEEPK, mlz 746.42+ AGDVLEDpSPKRPK, mlz 608.82+ 
APQTSpSPPPVR) showed no change in intensity with an average RSD of 17.9%. 
44 
In a separate study, the sensitivity and linearity response of Ti02 enrichment 
procedure was examined by loading a-casein (0, 25, 50, 100, 200, 400 & 800 fmol) spiked 
into 250 Ilg of 1774 cell extract onto 1.25 mg Ti02 micro-tips (n=3). The a-casein quantity 
ratio between different spike levels was determined to obtain the calculated fold change, 
which was then compared with the observed fold change obtained from intensity ratios of 
a-case in phosphopeptides of the Le-MS experiments. A graph of the observed and 
calculated fold change was plotted to determine the correlation between the estimated and 
experimental ratio. The changes in intensity measurements were also compared with five 
identified phosphopeptides (Mascot scores >25) of different intensities 
(RAGDVLEDpSPK, KAApSPpSPQSVR, ApSDPGLPAEEPK, AGDVLEDpSPKRPK 
and APQTSpSPPPVR) and originating from 1774 cell extract. As expected, no significant 
change in intensity (average fold change :s 1.05) was noted for phosphopeptides present in 
the original 1774 macrophage cell extracts (Fig. 2.3b). ln contrast, a linear recovery for the 
five most abundant a-casein phosphopeptides (VPQLEIVPNpSAEER, 
DIGpSEpSTEDQAMEDIK, TVDMEpSTEVFTK, EQLpSTpSEENSKK, and 
YKVPQLEIVPNpSAEER) was observed with an average correlation coefficient of r 2 of 
0.988 over two orders of magnitude in spike levels. A log-log plot of calculated and 
observed ratio is shown in Figure 2.3b for all pair-wise combination of spike levels. As 
indicated, a linear correlation between observed and calculated ratio was obtained over the 
spike range examined. AIso, the Ti02 isolation technique provides sensitive enrichment of 
phosphopeptides because a-casein digests spiked in 250 Ilg of cell extract were still 
detected at levels as low as 25 fmol (0.6 ng). Overall, the linear recovery of spiked a-casein 
digest provided evidence that even specific phosphopeptides present in complex cell 
extracts yield a linear response across different abundance levels. DifferentiaI 
phosphoproteome profiling can be performed to monitor abundance changes of enriched 
phosphopeptides across different cellular conditions. 
2.4.2 Evaluation of alkaline phosphatase treatment 
Many methods have been used in the past to confirm the presence of 
phosphorylation on a protein of interest [59, 63, 83, 85, 86]. Dephosphorylation of the 
phosphopeptide is the most straightforward and specific approach to confirm 
phosphorylation of the cognate peptide. For instance, comparison of two-dimensional gels 
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with the native protein and the AP-treated sample can specifica11y de termine if the protein 
is phosphorylated [89]. In this study, we report the application and analytical potentials of 
this method for large-scale proteomics analyses. The availability of enrichment methods 
providing high proportion of phosphopeptides (>80%) such as Ti02 micro-tips facilitates 
such differential display analyses by maximizing the number of putative assignments. This 
strategy consisted oftreating half of the TiOrenriched 1774 phosphopeptides with AP for 2 
h at 37°C in basic conditions and identifying a11 putative phosphorylated peptides using 
mass spectrometry and in-house bioinformatic tools (Fig. 2.4). 
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Figure 2.4: Overview of the analytical strategy combining enzymatic and data mining 
approaches. 1774 protein digest was initia11y enriched with Ti02 micro-tips and 
subsequently half of the eluate is treated with AP. Phosphopeptides treated and 
non-treated with AP were analyzed on a L TQ-Orbitrap mass spectrometer. In-
house bioinformatic software processed the data for subsequent matching of 
phosphopeptides and their dephosphorylated cognate by a set retenti on time and 
a mass difference (+ 5 min and 79.9663 Da) corresponding to phosphorylation. 
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The purity of the AP was first established from a silver stain gel of the enzyme 
preparation which showed a prominent band at 69 kDa for the expected enzyme with low 
abundance «1%) of protein contaminants (data not shown). The approach was then 
validated using a mixture of eight known non-phosphorylated proteins (glutamate 
dehydrogenase, aldolase, lactotransferrin, bovine serum albumin, a1cohol dehydrogenase, 
catalase, glycerokinase & lactoperoxidase) as a negative control. The non-phosphorylated 
protein mixture revealed no significant change in abundance when subjected to AP 
treatment where 97.5% of ion c1usters showed less than 1.5-fold change (Fig. 2.5a and b). 
The negative control confirmed that no proteolytic activity is present in the AP mixture 
other than dephosphorylation. Hence all changes observed following enzyme incubation are 
primarily attributed to the loss of the phosphate group. 
The specificity of this enzyme was also established using a-casein, which served as 
positive control. Preliminary experiments performed on native a-casein tryptic digest 
enabled the identification of six singly- and doubly-phosphorylated peptides. Consistent 
with previous investigations, peptides comprising a higher number of phosphorylated 
amino acids inc1uding QMEAEpSlpSpSpSEEIVPNpSVEQK and 
NTMEHVpSpSpSEESlIpSQETYK, were notably absent or of very low abundances [59, 
90]. In contrast, the analysis of the same non-enriched a-casein tryptic digest following AP 
treatment revealed all 10 dephosphorylated tryptic peptides inc1uding the penta-
phosphorylated peptide QMEAEpSlpSpSpSEEIVPNpSVEQK. From the comparison of 
peptide abundance across non-treated and AP-treated a-casein, 51.7 % peptide c1usters 
corresponded to non-phosphorylated peptides with changes in intensities lower than 1.5-
fold change (Fig. 2.5d). Also, the expression profile shows that II.6 % of peptide c1uster 
representing the phosphopeptide population are only present in the control sample. On the 
other hand, 36.7 % of potential dephosphorylated peptides are either observed with greater 
than 1.5-fold increase in intensity or uniquely detected in the AP-treated samples. The 
scatter plot of the corresponding analysis is shown in Figure 2.5c and illustrates all peptide 
c1usters with similar intensities along the 45° fine, whereas the peptides on the vertical and 
horizontal lines correspond to all ions only found in the phosphorylated and 
dephosphorylated forms. 
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Figure 2.5: Changes in peptide abundance of positive and negative control following 
AP treatment. Scatter plot of ion intensity for (a) eight protein digests non-
phosphorylated (200 fmol, 1073 peptide clusters) and (c) a-casein digest (200 
fmol, 767 peptide c1usters) with and without AP treatment. Vertical and 
horizontal lines indicate peptide ions observed only in control 
(phosphopeptides) and after AP treatment (dephosphorylated peptides), 
respectively. Expression plot showing the change in intensity of peptide ions for 
(b) eight protein digests (200 fmol) and (d) a-casein digest (200 fmol) following 
AP treatment. 
In total, 31 a-casein phosphopeptides with different charges and a tryptic peptide 
with a missed cleavage site were matched to their dephosphorylated counterpart by 
correlating changes in retention time (±5 min) and mass shifts (79.9663 Da). Examples of 
two a-casein phosphopeptides (YKVPQLEIVPNpSAEER and TVDMEpSTEVFTK) 
correlated to their dephosphorylated counterparts through the lost of one phosphate group 
are shown In Figure 2.6. However, another phosphopeptide 
(NTMEHVpSpSpSEESIIpSQETYK) was only detected upon AP treatment probably 
because it contained four phosphorylation sites (Fig. 2.6). 
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Figure 2.6: Comparison of non-treated and AP-treated a-casein contour plots. (a) 
Singly phosphorylated peptides from a-casein present on the peptide map of the 
non-treated a-casein (m/z 651.43+ YKVPQLEIVPNpSAEER & m/z 741.82+ 
TVDMEpSTEVFTK + oxidation). (b) AP-treated a-casein peptide map 
showing the presence of the corresponding dephosphorylated counterpart (m/z 
624.73+ & m/z 702.02+) and the appearance of a new peptide (m/z 772.3 3+ 
NTMEHVpSpSpSEESlIpSQETYK + oxidation) never detected previously in 
the phosphorylation form. 
Correlation of phosphopeptides with their dephosphorylated cognates allowed a 
direct comparison of their intensity and their elution time in LC-MS. Significant variations 
of retention time and abundance were noted for different pairs of phosphorylated peptides 
and their non-phosphorylated counterparts. F or instance, peptide paIr 
VPQLEIVPNpSAEER/ VPQLEIVPNSAEER had a retention time difference of Iess than 
0.5 min and an intensity variation close to I-fold. In contrast, the elution time for the 
doubly phosphorylated peptide, DIGpSEpSTEDQAMEDIK, increased by -1.5 min upon 
dephosphorylation, a change that was aiso accompanied by a 2-foid increase in intensity for 
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the corresponding peptide. Comparison of a-casein phosphopeptides to the AP-treated 
peptides revealed that dephosphorylation enhances ionization efficiency and conf ers 
unexpected changes in retention time that cannot be rationalized with simple structural 
rules. Rationalization of phosphopeptides behavior in LC-MS thus required a pool of 
phospho- and dephospho peptides for more meaningful statistical analyses. 
2.4.3 Phosphopeptide behavior in Le-MS 
Two major limitations attributed to the presence of the negatively charged 
phosphate group on the peptide are the suppression in ionization efficiency and the 
decrease in retention time on reverse-phase chromatography [62, 79]. To address this 
problem, Steen et al. [81] have investigated phosphopeptide behavior in LC-MS by 
selecting a small set of phosphopeptides. ln this study, we present a more comprehensive 
analysis of the retention time and intensity change performed on the large pool of tryptic 
Ti02- enriched 1774 phosphopeptides, including several multi-phosphorylated peptides, 
treated with AP. 
·lnitially, peptide lists obtained for the control and AP-treated samples were 
clustered together using in-house bioinformatic tools. A total of 14,147 peptide clusters 
were obtained where 759 (5%) corresponding to unspecific binding of non-phosphorylated 
peptides on Ti02 micro-tips were found in both conditions. To minimize the rate of false 
positive identification, common peptides were removed from the li st for subsequent 
correlation of mass (79.9663 Da) and retention time (±5 min) shifts between 
phosphopeptides and their dephosphorylated counterparts. The list of detected 
phosphopeptides matched with their dephosphorylated counterpart was aligned with the 
Mascot identification file (Mascot score >20) of phosphopeptides using in-house 
bioinformatic software. Similarly, in cases where only the dephosphorylated peptide was 
identified, putative phosphopeptides were determined by matching the detected 
phosphopeptide-dephosphorylated peptide pairs to the Mascot list (Mascot score >30) of 
assigned dephosphorylated peptides containing at least one Ser, Thr or Tyr residues. ln 
total, 686 unique peptides (764 peptides when considering sequences with multiple 
phosphorylation sites) were matched to their dephosphorylated counterpart where 234 were 
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putative phosphopeptides with a higher distribution of singly phosphorylation on serine 
residues (Table 2.2). It is noteworthy that we observed 531, 40, 3 phosphopeptides 
corresponding to Ser, Thr and Tyr phosphorylation sites, a relative distribution that is 
consistent with that observed by other groups [80]. 
Table 2.2: Statistics on ove raIl distribution of correlated phosphopeptides and their 
dephosphorylated counterparts from J774 AP study 
Category 
# Assignment 
# Phosphopeptides 
# Putative phosphopeptides 
Phosphopeptides with l, 2, 3 or 4 phospho sites 
Putative phosphopeptides with l, 2, 3 or 4 phospho sites 
Phosphorylated residues (Ser:Thr:Tyr) 
No. of examples 
686 
452 
234 
348, 87, 16, 1 
121, 73, 33, 7 
531,40,3 (92.5%,7.0%,0.5%) 
Figure 2.7a shows that non-phosphorylated peptides have very similar intensities 
before and after AP treatment, whereas the phosphopeptides and putative phosphopeptides 
showed an average fold-change of 1.5 and 2.0, respectively. It is noteworthy that 
dephosphorylated peptides uniquely found after AP treatment but not observed as 
phosphopeptides (624 identified peptides of which 210 were already known in the 
literature) were not considered in this comparison. Higher proportion (> 60 %) of multi-
phosphorylated (two, three and four HP03 groups) peptides have an intensity increase 
greater than 2-fold upon dephosphorylation compared to the singly phosphorylated peptides 
(-33%). These results support the proposaI that phosphorylation can suppress MS signal in 
positive ion mode [79]. 
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Figure 2.7: Phosphopeptide behavior in Le-MS following alkaline phosphatase 
treatment (n=3). (a) The intensity fold change (ratio of dephosphorylated peptide 
over phosphopeptide) distribution for phosphopeptides (351), putative phosphopeptides 
(224) and non-phosphorylated peptides (41) identified with a Mascot score >20. The 
average fold change for the latter were 1.5, 2.0 and 1.0, respectively. Putative 
phosphopeptides were deterrnined by matching the detected phosphopeptide-
dephosphorylated peptide pairs to the Mascot list of assigned dephosphorylated 
peptides containing at least one Ser, Thr or Tyr residues. Following AP treatment, more 
than 40% of dephosphorylated peptides had an abundance increase higher than 2-fold, 
whereas this was the case for only 2% of the non-phosphorylated peptides. (b) 
Variation of retenti on time for correlated phospho- and dephosphorylated peptides in a 
two-step linear gradient from 2% to 25% B over 63 min followed by a gradient from 
25% to 40% over 15 min. Phosphopeptides (369) and putative phosphopeptides (271) 
were distributed across ± 5 min retenti on time upon AP treatment whereas non-
phosphorylated peptides (41) only had an elution time difference less than 0.6 min 
compared to the AP-treated peptides (Mascot score >20). Arrows indicate 
phosphopeptides from a-casein. 
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Our studies have also revealed that a large number of phosphopeptides displayed a 
more hydrophobic character than their dephosphorylated counterpart. No significant change 
in retention time was observed for the 41 non-phosphorylated peptides (Mascot score> 30 
& <0.6 min variation) upon AP treatment (Fig. 2.7b). On the other hand, only 55% of 
matched phosphopeptides had a retenti on time difference (RT dephospho - RT phospho) 
less than 1 min whereas 24 and 21 % had a decrease or increase in retention time of more 
than 1 min respectively. For convenience, phosphopeptides corresponding to spiked Œ-
casem are indicated by an arrow on Figure 2.7b. Interestingly, several multi-
phosphory1ated peptides (28%) eluted much 1ater (> 1 min) than their dephosphorylated 
counterpart, and -30% had a smaller retenti on time (Fig. 2.7b). The unexpectedly large 
population of phosphopeptides of greater hydrophobicity than their dephosphorylated 
counterparts was intriguing and warranted further investigations. 
Several peptide characteristics were evaluated to understand the phosphopeptide 
behavior in LC-MS analysis. We systematically examined physicochemical properties of 
phosphopeptides such as peptide length, pl, hydrophobicity, charge, polarity and amino 
acid composition to correlate structural changes with corresponding shift in retenti on times. 
Regrettably, none of these properties could be correlated with the observed retenti on time 
shift. We next looked at the location of basic and acidic residues and N -terminus from the 
phosphate group within the singly phosphorylated peptide. Only one distinct distribution 
examined showed that phosphorylated residues proximal to the N-terminus typically eluted 
later than their dephosphorylated counterpart (Fig. 2.8). AIso, phosphate groups closer to 
the C-terminus had elution time difference > 1 min upon dephosphorylation. On the other 
hand, the location of phosphorylation site for peptides with unchanged retention time upon 
dephosphorylation showed no particular trend (Fig. 2.8). One possible explanation for this 
effect can be attributed to the salt bridge formation between phosphate groups and the basic 
residue. In this case, the electrostatic interactions can diminish the overall polarity of the 
phosphopeptide thus conferring a more hydrophobic character compared with its 
dephosphorylated counterpart where no salt bridge can be formed. 
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Figure 2.8: Distribution of matched phospho- and dephosphorylated peptides with 
different /). retention time according to the phosphate group position from 
both C and N-terminus. (a) Representation of singly phosphorylated peptides 
with a /). retention time (AP-treated RT - non AP-treated RT) >2 min and <-2 
min. (b) Distribution of singly-phosphorylated peptides with an unchanged 
(between 1 and -1 min), positive (> 1 min) and negative «-1 min) /). retention 
time. Phosphopeptides containing phosphate groups closer and further to the N-
terminus have negative and positive retention time shifts, respectively. On the 
other hand, phosphopeptides with unchanged retention shift have modification 
sites distributed across aIl the peptide sequence. 
To test this proposaI, we enriched a-casein tryptic digest with Ti02 micro-columns, 
derivatized free amino groups with acetic anhydride and compared the shift in retenti on 
time of the corresponding peptides following AP treatment. The differences in retenti on 
times were also compared to those of non-acetylated peptides (Fig. 2.9). Without N-
acetylation, a-casein phosphopeptides showed positive and negative retenti on time shifts 
when compared to the elution of their dephosphorylated counterparts. It is noteworthy that 
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the non-phosphorylated peptide NANEEEYSIGSSSEESAEV A TEEVK and its N-
acetylated derivative showed no significant change in retenti on time following AP 
treatment irrespective of the number ofN-acetylated groups. However, upon AP treatment 
a positive shift in retenti on time was observed for the N-acetylated phosphopeptides 
indicating an increase of the hydrophobicity of the corresponding dephosphorylated 
peptides. Two exceptions to this were noted for the phosphopeptides 
DIGSESpTEDQAMEDIK and FQpSEEQQQTEDELQDK where the acetylated derivative 
could not be detected in positive ion mode presumably due to their overall negative charge. 
Interestingly, these phosphopeptides were also more hydrophobie than their 
dephosphorylated counterpart. 
4 
• Non-acetylated 
--
3 ~ One acetylation 
= 5 [l Two acetylation 
'-' 
0 2 
.c 
Q. 
ri) 
0 
.c 
Q. 
1 
0 
.c 0 Q. 
ri) 
0 
.c 
-1 Q. 
~ 
"0 
f-
-2 cr::: 
= 
.:::: 
~ ... Q -.) 
-4 
~ ~ ~ ~ ~ ~ c:: c:: VJ 
i5 0 (1) ~ ~ f- t.ù t.ù t.ù 0' c.. VJ r/) u... t.ù t.ù t.ù t.ù ....l Z Z > « « VJ ~ ....l t.ù r/) t.ù Z t.ù t.ù fl.l (1) (1) VJ 
« 0 t.ù t.ù ~ c.. c.. S2~ 0' t.ù > (1) (1) Z Z 
0 f- ~ c.. c.. c.. 0.. 0.. r/» t.ù f- f- t.ù > > >-t.ù t.ù 8 r/) (1) ~ t.ùt.ù f- ....l c.. 0 t.ù t.ù t.ù. c.. 0' 0' ....l ....l ....l t.ù r r/) t.ù t.ù 0' > 0' 0' z:; t.ù t.ù t.ù f- 0.. 0.. 
r/) (1) > > «t.ù 0 c.. ~ z« i5 0' >-u.. 
Figure 2.9: Comparison of retention time shifts of a.-casein phosphopeptides and their 
N-acetylated counterpart following AP treatment. 
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Although these results are consistent with a salt bridge model, secondary structural 
changes on the peptide conformation following AP could also influence the extent of 
retention time shift. Further structural studies on these aspects are currently underway and 
will be reported separately. 
2.4.4 Application of alkaline phosphatase treatment for large-scale phosphoproteomic 
analyses 
The AP approach was further evaluated for a more comprehensive characterization 
of the differentially expressed phosphoproteome following stimulation of J774 mouse 
macrophage cells by IFN-y. Initially, control and macrophage cells incubated with IFN-y 
for 5 min were digested with trypsin and phosphopeptides were isolated using Ti02 affinity 
media prior to their LC-MSIMS analyses on a LTQ-Orbitrap mass spectrometer. The 
reproducibility of three replicates of control and IFN-y treated samples was initially 
assessed to validate meaningful expression changes of identified phosphopeptides. More 
than 95% of peptide clusters showed less than 80% intensity variation indicating that 
peptides with 2:2-fold change in abundance provided statistically meaningful variation. 
Following peptide clustering analysis, expression profiling was performed to compare the 
phosphopeptide abundance in two different conditions. All reproducible changes taking 
place between control and IFN-y treated samples were represented on a volcano plot (Fig. 
2.10a). The comparison of the macrophage phosphoproteome with and without IFN-y 
indicated that 68% of all 6170 ion clusters showed less than 2-fold change in abundance 
across biological replicates and conditions (n=3) whereas 12% (763) and 20% (1218) ion 
clusters showed more than 2-fold over- and under-expression, respectively. 
56 
a) No AP treatrnent 
6 
Control • 10 IFN-gamma 5 
·1 1 • 
10 • 
- •• "l ~ 4 1 e 
= 
- • eo: , 
1 3 c. • 
'-" 
:: • 
~ 2 • Q 
-1 
• • 
--------- ---------0 0 
o 0 
0 
-6 -5 -4 "' -2 -1 0 1 2 3 4 5 6 -.) 
IOg2 (fold change) 
b) AP treatrnent 
6 
1 1 
1 .. 
5 Control • • 1 01 IFN-gamma 
l 1 
-
• 
"l ~~ ~ 4 • [) 
- %~ f· -
-eo: 
• , 
1 3 • c. 
'-" 
:: • • ~ 2 Q 
• 
-1 4"!!-------
o 0» 
fi 8 0 0 
<t 
eo o§t #<>6 000 0 0 
0 
-6 -5 -4 "' -2 -, 0 , 2 3 4 5 6 -.) 
IOg2 (fold change) 
Figure 2.1 0: Volcano plot distribution of (a) non-treated and (b) AP-treated cytosolic 
extracts of J774 control and IFN-"( treated (5 min). Only peptide c1usters 
containing intensity values in aIl three replicates of the control and IFN-y 
treated samples were considered. SaUd line divides peptide c1usters more 
abundant in control and IFN-y samples. Dashed lines delimit peptide 
populations showing 2-fold change in abundance with p-values <0.05. Squares 
identify aIl phospho and dephospho-peptides listed in Table 2.4. 
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AIso, LC-MSIMS analysis with the LTQ-Orbitrap mass spectrometer resulted in 
716 and 917 phosphopeptides (Mascot score >20, n=3) in the control and IFN-y stimulated 
samples, respectively (Table 2.3). In total, 1143 unique phosphopeptides from 432 different 
proteins were detected where 125 phosphopeptides showed a 2-fold change upon IFN-y 
administration. 
Table 2.3: Summary of identification obtained from different approaches 
# Phosphopeptides 
# Non-phosphorylated peptides 
# Phosphoproteins identified 
# Putative phosphopeptides 
Non-treated AP-treated 
Control IFN-y Control IFN-y 
716 917 1306* 1569* 
171 225 
291 340 577* 
716 
638* 
872 
*Newassignments (i.e. without non-phosphopeptides found in control) 
To ob tain a higher number of phosphopeptides, half of the Ti02-enriched control 
and IFN-y treated (5 min) 1774 cell extract were incubated with AP and analyzed on the 
L TQ-Orbitrap mass spectrometer. Comparison of both volcano plots in Figures 2.10, a and 
b, showed a -2-fold increase in putative phosphopeptides aft~r AP treatment. In fact, 61.4% 
(8493) and 32.9% (4558) of peptide c1usters showed 2-fold increase in the AP-treated and 
non-treated control 1774 cell extract, respectively. Similar results were obtained for the AP-
treated IFN-y sample (63.4%, 8439 peptide c1usters and 30.9%, 4111 peptide c1usters), 
further supporting the notion that phosphopeptide ions are under-represented in positive ion 
peptide maps due to suppression effects [79]. Upon enzyme treatment, better MSIMS 
spectral quality was obtained for the dephosphorylated peptides, and a higher score was 
assigned by Mascot (Fig. 2.11, c and d, and 2.12, band d). In fact, more than 90% of 
identified phosphopeptides had a significant higher score following AP treatment. For 
instance, 65% of dephosphorylated peptides showed an increase of 20 in their 
corresponding Mascot score compared to the phosphorylated counterpart. Not only the 
confidence level of identification increased but the number of putative phosphopeptides 
identified doubled to 1306 and 1569 for control and IFN-y sample, respectively (Table 2.3). 
AIso, less than 7.6 % of the entire pool of AP-treated samples corresponded to incompletely 
dephosphorylated peptides probably originating from very abundant phosphopeptides or 
peptides structurally incompatible to AP dephosphorylation. 
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Putative phosphopeptides can be identified from peptide ions showing an increase 
in abundance higher than 2-fold upon phosphatase treatment. For instance, the peptide 
EVEEDSEDEEMSEDEDDSSGEEEVVIPQKK (m/z 1147.83+) from nucleolin protein 
showed a 13-fold increase in abundance upon AP treatment. Yet the corresponding 
phosphopeptide was never detected in the non-treated sample proving that phosphopeptides 
do not ionize as efficiently as their dephosphorylated counterpart. This lower ionization 
efficiency can be probably explained by the high number of phosphorylation sites (four) 
already known in the literature for this peptide 
(EVEEDpSEDEEMpSEDEDDpSpSGEEEVVIPQKK). In short, the AP strategy provides 
a meaningful tool to uncover the presence of putative phosphopeptides where only the 
dephosphorylated counterpart is present in the AP-treated sample. This analysis also 
provides a mean to de termine stoichiometry of phosphorylated and non-phosphorylated 
peptides by comparing changes in intensity ratio of the dephosphorylated peptides in the 
control and AP-treated samples. 
Moreover, the mass shi ft (HP03: 79.9663 Da) associated with phosphorylation 
together with the variation in intensities and retention times were integrated in data mining 
softwares to identify potential phosphopeptide candidates following AP treatment. Peptide 
maps of control and phosphatase-treated macrophage cell extracts were compared and 
results obtained indicated that 2723, 1457,495, 194 and 85 (3920, 1918,582,259 & 105 
for IFN-y) peptide ion pairs were correlated with the addition of one, two, three,' four and 
five phosphate groups, respectively. For instance, the phosphopeptide 
(EELApSDLEEMATSSAK) originating from nucleolar protein Nop56 [91] was identified 
in the AP-treated (m/z 855.92+, 57.5 min) and non-treated control (m/z 895.92+, 57.6 min) 
sample (Fig. 2.11a-d). Interestingly, more than 7325 and 7384 potential phosphopeptides in 
the control and IFN-y mixtures were only detected in the AP-treated sample and were 
absent in the corresponding non-treated sample. For instance, Figures 2.l1a-b showed the 
presence of the putative phosphopeptide, TQSLQDFPV AD~EEEAEEEFQK, from 
Tuftelin-interacting protein Il [92] only after AP treatment, and the phosphorylation site is 
already known in the literature (pS211). 
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Figure 2.11: Identification of phosphopeptide candidates using alkaline phosphatase. 
Contour profile of m/z versus. time for phosphopeptide-enriched extract from 
1774 (a) without and (b) with AP. MSIMS spectra for (c) m/z 895.882+ 
(Mascot score 71) and (d) m/z 855.882+ (Mascotscore 121) corresponding to 
Nuc1eolar prote in Nop56 and (e) m/z 886.383+ (Mascot Score 35) 
corresponding to Tuftelin-interacting prote in Il. 
All identified phosphopeptides listed in Table 2.4 are highlighted as squares in the 
volcano plot in Figures 2.1 Da-b. Among phosphoproteins showing statistically meaningful 
change in abundance was cytosolic phospholipase A2 (cPLA2) [93] (CSVpSLSNVEAR, 
pS727) where a 2.6-fold increase in abundance was observed upon IFN-y treatment in the 
phosphorylated and dephosphorylated form (Fig. 2.12, a and c). Also, IFN-y treatment 
induced dephosphorylation of eukaryotic translation initiation factor 4B (eIF4B) [3] 
(pSLENETLNK, pS445) which is involved in mRNA translation. 
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Figure 2.12: Identification of differentially expressed phosphoproteins from J774 
following 5 min IFN-y stimulation. Reconstructed ion chromatograms of 
cPLA2 (a) phosphopeptide m/z 651.32+ with (b) its corresponding 
dephosphorylated counterpart m/z 611.32+ and 40S ribosomal protein S6 (c) 
dephosphopeptide m/z 525.32+ showing differential abundance in control and 
IFN-y exposed cells. Solid lines correspond to control digests and dotted lines 
to IFN-y treated samples. MSIMS spectra of precursor ions (b) mlz 651.3 2+ 
(Mascot score 56) (d) m1z 611.32+ (Ma scot score 87) and (t) mlz 525.32+ 
(Mascot score 57) confirrning identification of cPLA2 in control and AP 
treatment, and the 40S ribosomal protein S6 after AP treatment only. 
Table 2.4 indicates that only a small number of phosphoproteins such as cPLA2 and 
eIF4B showed stoichiometric change in phosphorylation upon IFN-y treatment, suggesting 
an under representation of the phosphopeptides population leading to an incomplete 
characterization ofthe corresponding signaling pathways. Hence, AP treatment was applied 
to further characterize differentially regulated phosphoproteins in response to IFN-y 
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stimulation. A volcano plot representing AP-treated control and lFN-y stimulated J774 cells 
showed that 69.7% of aU 10,763 peptide c1usters were within 2-fold intensity change 
whereas 15.5% (1664) and 14.8% (1594) had a decrease and increase in peptide abundance, 
respectively (Fig. 2.l0b). The high number ofnewly detected putative phosphopeptides led 
to the identification of more early signaling and regulatory events inc1uding the enhanced 
phosphorylation of ROS complex members su ch as p40Phox (GV§PQGAlMDR, S16l), 
which was not identified in the previous analysis, and the phosphosite was never before 
reported in the literature (Table 2.4). Another interesting finding was AP-3 complex protein 
(RHSSLPTE§DEDlAPAQR) involved in vesic1e formation and was only detected upon AP 
treatment with a known phosphosite at Ser760 [94]. ln addition, the phosphatase approach 
enabled a more complete characterization of the initiation of mRNA translation mediated 
by IFN-y. Changes in phosphorylation of important phosphoproteins such as putative RNA-
binding protein Luc7-like 1 (§EEKEAGEI) and 40S ribosomal prote in S6 (LSSLRASTSK) 
were also identified further confirming the importance of mRNA translation upon 
macrophage activation [3]. Figure 2.l2e shows the change in abundance upon IFN-y 
treatment of 40S ribosomal protein S6 foUowing AP treatment. lt is noteworthy that no 
phosphopeptide containing one, two or three phosphate groups was detected in any of the 
control samples examined. ln brief, the AP approach enabled a more comprehensive 
representation of aU phosphoproteins involved in the signal transduction pathways ofIFN-y 
stimulated macrophages. 
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Table 2.4: Putative phosphopeptides showing differential abundance in 5 min IFN-y stimulated J774 cytosol extracts upon AP 
treatment 
Putative phosphopeptides 
Fold chan~e 
Proteins Function Non-treated AP-treated 
(E-values2 (E-values2 
CSVpSLSNVEAR Cytosolic phospholipase A2 (cPLA2) ROS production 2.6 2.6 
~0.001~ ~0.002~ 
GVSPQGAIMDR Neutrophil cytosol factor 4 (p40PhOX) ROS production 4.9 
~0.032~ 
FSEMMDHMGGDEDVDLPEVDGAD Prostaglandin E synthase 3 Production ofPGE2 -2.1 
DDSÇDSDDEK ~0.027~ 
HpSGQDVHVVLK NSFL 1 cofactor p4 7 Vesicle trafficking -2.1 -2.9 
~0.03Oî ~0.004î 
RHSSLPTESDEDIAPAQR AP-3 complex subunit delta-l Vesicle trafficking 2.1 
~0.038l 
QPSIELPSMA V ASTK Lymphocyte-specific protein 1 isoform 2 Vesicle trafficking 4.8 3.0 
~O.OOll ~O.OOll 
LSSLRASTSK 40S ribosomal protein S6 mRNA translation 2.5 
~0.029~ 
SEEKEAGEI Putative RNA-binding prote in Luc7-like 1 rnRNA translation 7.2 
~O.OOOll 
IDASKNEEDEGHSNSSPR Heterogeneous nuclear ribonucleoprotein DO (AUFl) mRNA translation 4.3 
~0.016l 
KAApSLTEDR Eukaryotic translation initiation factor 4-y 1 isoform b rnRNA translation 1.8 2.6 
~eIF4GQ ~0.044l ~0.006l 
pSLENETLNK Eukaryotic translation initiation factor 4B (eIF4B) mRNA translation -2.7 -4.5 
~0.0002l ~0.003l 
pTPEFLR Elongation factor l-y (eEF-IB gamma) isoform 1 mRNA translation -2.3 ND 
(0.0052 
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2.5 Discussion 
ln summary, we report the analytical potentials of a strategy using AP to detect a 
higher number of phosphopeptides in complex mixtures. The AP approach was 
validated with a negative and positive control, which confirmed that the enzyme had 
high selectivity and enabled specific dephosphorylation of a wide range of substrates. In 
fact, the mixture of non-phosphorylated peptides showed no change in abundance upon 
enzyme incubation further supporting the notion that AP has no proteolytic activity 
other than dephosphorylation. AIso, the high performance of the AP approach, even for 
multi-phosphorylated peptides, was greatly demonstrated through the analysis of the 
standard phosphoprotein, a-casein. 
For a successful application of the AP treatment on large-scale experiments, 
enrichment of phosphopeptides is absolutely required to simplify the mixture and obtain 
enhanced MS detection. The evaluation of two different phosphopeptide isolation 
procedures using Ti02 and !MAC (Ga3+) micro-columns revealed that Ti02 extraction 
offered a higher number of phosphopeptides and enrichment level than the !MAC 
procedure. Aiso as stated by Bodenmiller et al. [82], W y confirmed that complementary 
phosphopeptide populations are obtained with Ti02 and IMAC (Ga3+) isolation 
methods. Ti02 seemed to have higher affinity towards singly phosphorylated peptides 
and DHB loading solution defmitely helped to displace most non-phosphorylated acidic 
residues. On the other hand, IMAC retained mostly multi-phosphorylated peptides but 
provided a much lower enrichment level (-37%) than Ti02 micro-tips (-77%). 
Thingholm et al. [95] also reported this difference in selectivity of both stationary 
phases (IMAC and Ti02) towards phosphopeptide and further suggested to combine 
both enrichment methods for optimal recovery. For our analysis, phosphopeptides were 
isolated using only Ti02 micro-tips since it provided the best overall performance. The 
optimal loading capacity of Ti02 enrichment procedure was 250 )lg of cell extract 
loaded onto a 1.25 mg Ti02 offering a linear recovery of spiked a-case in ranging from 
25 to 800 fmol. 
Enrichment of phosphopeptides has been the most straightforward approach to 
identify phosphopeptides and their corresponding phosphorylation site. Yet it has been 
demonstrated that sorne peptides remain undetected in positive ion mode MS possibly 
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due to their multiple phosphorylation. Hence to obtain the most complete coverage of 
aIl phosphopeptides in the sample, several groups have recently shown that treating the 
enriched mixture with AP reveals the presence of a high number of phosphopeptides 
[63, 85], [86], [96]. One major drawback of AP approach is that no information on the 
location of the phosphorylated site is revealed, a limitation that is even more evident 
when more than one potential residue is present. However, this approach will still 
provide insight on potential phosphopeptides which can be further identified by targeted 
MS/MS analysis. In-source activation can be used to promote the formation of 
phosphopeptides fragments baring the dehydroalanine or dehydrobutyrine moieties for 
confirmation by MS/MS. For large scale experiments, AP treatment is still the preferred 
strategy over ~-elimination to directly confirm the presence of the phosphate group on 
the protein. In fact, phosphatase treatment on Ti02-enriched 1774 mouse macrophage 
protein digest showed that a large fraction of phosphopeptides were only detected upon 
dephosphorylation. These results further strengthen the notion that the mass 
spectrometry analysis of phosphorylated peptides is limited. The identification level 
almost doubled upon AP treatment confirming that positive ion detection coupled to 
reverse-phase LC method is not fully optimized to detect aIl phosphopeptides. Further 
understanding of phosphopeptide behavior in LC-MS is required to better predict 
phosphopeptide detection in positive ion mode. Our study showed that 
dephosphorylated peptides can vary significantly in abundance foIlowing AP treatment 
with a large proportion (~40 %) showing a 2-fold increase in intensity upon 
dephosphorylation. The occurrence of new peptides upon AP treatment demonstrates 
that sorne phosphopeptides cannot be detected by MS in positive ion mode. Likewise, 
Nielsen et al. [97] provided evidence that posttranslational modifications such as 
phosphorylation on hydrophobic peptides yielded a lower ESI signal response. Steen et 
al. [81] suggested otherwise by showing that most tested phosphopeptides still had 
similar ionization efficiency compared to their unphosphorylated cognates. Yet their 
work reflected the behavior of only few selected synthetic peptides where a smaIl 
number comprised doubly phosphorylated peptides. 
Another interesting observation mentioned by Steen et al. [81] and lshihama et 
al. [85] was that sorne phosphopeptides actually eluted much tater than their 
dephosphorylated cognate. Similarly our study revealed that a high proportion of 
dephosphorylated peptides were more hydrophilic than their phosphopeptide 
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counterparts. So far, this study is the first one presenting a large list of detected 
phosphopeptides to rationalize phosphopeptide behaviour in LC-MS. Theoretically, 
removal of a phosphate group should lead to an increase in hydrophobicity of the 
peptide, yet these results show otherwise. Many different parameters (peptide length, pl, 
hydrophobicity, charge, polarity, and amino acid composition) were studied to probe the 
reason behind this surprising change in R T upon dephosphorylation. However, from 
those characteristics, no coherent reasoning was found to completely explain changes in 
retenti on times occurring upon dephosphorylation. Hence we looked more closely at the 
influence of salt bridges on a phosphopeptide conformation. Our data suggested that 
possible intramolecular electrostatic interactions take place between the N-terminus and 
phosphate group rendering the peptide more hydrophilic upon dephosphorylation. Since 
phosphopeptides are dissolved in acidic conditions of pH 3.0 for LC-MS analysis, the 
phosphate group is negatively charged because of its lower pKa of 1-2. Hence salt 
bridges can occur between phosphate groups and the positively charged N-terminus 
reducing overall charge and rendering the phosphopeptides more hydrophobic. This 
proposaI was also supported from the retention time behavior of a-casein N-acetylated 
phosphopeptides where an increase in retention time was consistently observed upon 
AP treatment in contrast to the non-derivatized phosphopeptides. In a similar fashion, 
few studies have shown that introduction or removal of a phosphate group completely 
destroys the stability and conformation of the peptide since salt bridges are disrupted 
from basic or N-terminal residues [98, 99]. Conformational studies of phosphopeptides 
secondary interactions are presently in progress to further characterize possible effects 
that will reveal a more complete reasoning of the model. 
Subsequently, the analytical potentials of AP strategy were conveyed through 
the further understanding of a biological model. Over the past decades, the identification 
of phosphorylation sites has become a primordial need for the full understanding of cell 
division, cancer therapy and ev en signal transduction in inflammatory response. To 
survive from viral infections, several mechanisms have evolved to recognize and 
eliminate invading organisms [100]. Inflammatory response is commonly initiated by 
the secretion of IFN-y by T -cells that activates important antiviral mechanisms such as 
the JAK-ST AT pathway in macrophages. In the present experiment, we did not observe 
any phosphopeptide associated with the JAK-STAT pathways possibly due to their 
relatively low abundance in cytosol extracts and the incompatibility oftheir 
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physicochemical characteristics with the present LC-MS systems (i.e. high 
hydrophilicity and m/z values outside of scanning range). However, we identified 
several phosphoproteins associated with bactericidal activities of macrophages. Indeed, 
many additional downstream substrates are stimulated through phosphorylation and 
direct the elimination of the microbe by phagocytosis or the release of reactive oxygen 
species (ROS) and hydrolytic enzymes [3]. Hence, phosphoproteome analysis in 
stimulated macrophages is essential for a better understanding of the innate immunity to 
potential pathogens. Pathogen destruction by phagocytosis is an important step for the 
inflammatory response [101]. Upon IFN-y stimulation, Hefner et al. [102], 
demonstrated that cPLA2 is activated through Ser727 phosphorylation by mitogen- and 
stress-activated protein kinase 1 (MSK 1) involved in the JAK/ST AT pathway. 
Stimulated cPLA2 hydrolyzes membrane phospholipids from the sn-2 position to release 
arachidonic acid (AA) which in turn translocates p47Phox to the cell membrane. [103]. 
Concomitantly, IFN-y priming of macrophages triggers phosphorylation of p40PhoX, 
p47phox and p67phOX which are translocated from the cytoplasm to the membrane to 
associate with cytochrome b558 and form the NADPH oxidase enzyme complex [101]. 
Hence the phosphorylation change taking place in both pathways is necessary for the 
translocation of neutrophil cytosolic factors to the cell membrane. The resulting 
activated complex catalyzes the electron transfer from NADPH to O2 to generate a burst 
oftoxic superoxide (02-) which helps in the killing ofphagocytosed microorganisms. In 
our preliminary phosphoproteome analysis using Ti02 enrichment only, we observed a 
limited number of kinase substrates su ch as cPLA2 (Ser727) which showed 
stoichiometric changes in phosphory\ation following IFN-y stimulation. However, a 
greater number of differentially phosphorylated proteins involved in the production of 
ROS including p40Phox were detected upon AP treatment. 
The advantages of dephosphorylating phosphopeptides also allowed the 
characterization of another IFN-y stimulated pathway covering the formation of 
vesicles. Vesiculation is generated by 5 different adaptor proteins, AP l, AP2, AP3, coat 
protein 1 (COPI) and coat protein U (COPU). AP-3 complex originates from the Golgi 
and endosomal membranes [104]. Studies have shown that upon phosphorylation, the 
AP-3 complex is recruited by V AMP-2 to form the coat assembly for pseudopod 
extension and vesicle formation involved in the pathway to lysosomes [105, 106]. In our 
study, the putative phosphopeptide RHSSLPTE~DEDIAPAQR from AP-3 complex 
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prote in had an ~2-fold increase in abundance upon macrophage activation. To our 
knowledge, no paper has yet reported the possible direct linkage of IFN-y priming to the 
enhanced phosphorylation of AP-3 complex and subsequent vesiculation. 
In addition, our study allowed further characterization of the mRNA translation 
signaling pathway mediated by the action of IFN-y. Cytokine stimulation has the ability 
to block cell growth and inhibit viral replication. Yet, it will also induce rnRNA 
translation and protein synthesis of selective IFN-sensitive genes [31]. The regulatory 
mechanisms of prote in synthesis is known to be mediated very quickly (minutes) 
through changes of phosphorylation state of translational machinery components 
reflecting the variations observed upon 5 min incubation of IFN-y with 1774 cells [107]. 
So far, an incomplete description of protein synthesis signaling pathway has been 
obtained for cells stimulated by IFN-y [3]. Scheper et al. [l08] demonstrated that 
eukaryotic translation initiation factor 4B (eIF4B) binds the 5'-cap structure of the 
rnRNA more tightly in its dephosphorylation form. Likewise, our analysis revealed a 
4.5 fold decrease in phosphorylation of the eIF4B phosphopeptide (pSLENETLNK) 
upon IFN-y treatment. In addition, our study detected an increase in phosphorylation for 
eIF4G (KAApSLTEDR, Ser121l) upon IFN-y induction. Earlier reports proposed the 
implication of eIF4G 1 phosphorylation in the mTOR pathway but no clear functional 
effect has yet been recognized [107]. AIso, it has been previously shown that the mTOR 
pathway required phosphatidylinositol 3-kinase (P13K) activation induced by type II 
IFN signaling with p70 S6K/rpS6 and 4E-BPI as putative downstream effectors [3]. 
Upon cytokine induction, the p70 S6 kinase is rapidly activated by phosphorylation, 
which will in turn phosphorylate 40S ribosomal prote in S6 on Ser235-236. During the 
initiation step, 40S ribosomal protein S6 is recruited to the rnRNA for the identification 
of the start codon [107]. Until now, only the phosphorylation of 40S ribosomal protein 
S6 upon IFN-y was shown to regulate rnRNA translation but the exact function 
remained unclear [107]. After AP treatment, we were able to identify the 40S ribosomal 
protein S6 phosphopeptide, LSSLRASTSK, with three possible phosphorylation sites 
already known in the literature (Ser235-236, 240) including those responsible for the 
regulation of mRNA translation. Upon IFN-y stimulation we identified significant 
changes in the phosphorylation state of other proteins involved in the prote in synthesis 
machinery such as elongation factor l-y (eEF-IB-y) isoform 1 and heterogeneous 
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nuclear ribonucleoprotein DO. The direct implication of these phosphoproteins with 
inflammatory response has not been reported in the literature. 
The AP strategy enabled a more comprehensive study of the change in 
phosphorylation following IFN-y signaling highlighting known and novel activation 
pathways in macrophages. Validation of potential phosphorylation sites can be 
subsequently obtained using independent techniques such as Western blotting and site 
mutagenesis. We anticipate that the broader application of AP in quantitative 
phosphoproteome studies of Ti02-enriched protein extracts will provide a 
complementary and meaningful analytical strategy to uncover signaling pathways that 
remain elusive with current methodology. 
-------------------- --
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3.1 Abstract 
IFN-y induction of macrophages activates several signaling networks primarily 
modulated by reversible phosphorylation to overcome inflammatory diseases. The 
impact of IFN-y stimulation is well-defined for the JAKJSTAT pathway but is still 
po orly understood in other cell signaling events. In the present study, phosphoproteome 
analysis in macrophages using the sensitive mass spectrometry-based strategy provided 
a better understanding of the immune response. We conducted kinetic profiles up to 180 
min of IFN-y administration to mouse 1774 macrophages in order to follow 
phosphoproteome dynamics. Phosphopeptides from tryptic digests of cytosolic proteins 
were isolated using Ti02 affinity media and analyzed by L TQ-Orbitrap mass 
spectrometry. Amongst the different trends observed, a higher proportion of 
phosphopeptides showed a change in phosphorylation after 5 and 30 min of IFN-y 
administration. In a more extensive study, a total of 2,831 non-redundant 
phosphopeptides were identified for 1774 cell extracts treated for 0, 5 and 30 min with 
IFN-y using 2D-LC-MS/MS analysis. This number included 1,673 new phosphorylation 
sites providing novel insights on IFN-y stimulated pathways. According to kinase 
prediction and motif analyses, phosphopeptides containing consensus sequences 
recognized by CK.2, CDK.2 and MAPK14 kinases were up-regulated upon IFN-y 
treatment. Phosphoprotein networking analysis indicated that rnRNA translation and 
apoptotic pathways are regulated by early and late signaling events, respectively. 
Protein networks showed statistically meaningful changes in abundance for key 
phosphoproteins involved in protein synthesis, apoptosis, cytotoxic molecules formation 
as weIl as phospholipid signaling. The identification of known and novel 
phosphoproteins (PEA-15, RSK-2 and NF~KB) involved in the apoptotic pathway 
suggested a potential activation of cell death upon cytokine priming. OveraIl, the 
identification of important phosphorylation events upon IFN-y induction led to a more 
comprehensive characterization of cytokine signaling pathways in macrophages. 
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3.2 Introduction 
Cell signaling of the immune system consists of an interconnected network of 
pathways associated with various regulatory processes to induce acute inflammatory 
response. Specialized cells such as macrophages are responsible for ingesting and 
degrading dead cells and various pathogens through phagocytosis. Then, peptides from 
the degraded particles are presented to T cells for subsequent activation of the adaptive 
immune response [109]. 
Inflammatory response is commonly initiated by the secretion of interferon-y 
(IFN-y) from T-celIs, which subsequently activates macrophages [12]. For several 
years, IFN-y was used as a therapeutic agent to treat infectious diseases such as chronic 
rriyelogenous leukèmia and hepatitis B and C [84, 110]. This cytokine binds to the 
membrane receptor IFNARl, which in tum activates several signaling pathways in 
macrophages [1]. The first weIl studied signaling nètwork involved the nuclear 
translocation and initiation of gene transcription by ST ATs following JAK 
phosphorylation [111]. Many important proteins implicated in cytoskeleton 
rearrangement, cell cycle progression, gene transcription, mRNA translation and 
production of reactive oxidative species (ROS) and nitric oxide (NO) intennediates 
were already shown to partake during IFN-y macrophage activation [9, 109]. 
IFN-y regulated pathways are primarily guided through post-translational 
modifications (PTMs) ofproteins. Several studies have shown the important implication 
of prote in phosphorylation-dephosphorylation throughout IFN-y mediated cascades 
[111, 112]. Protein phosphorylation is the most abundant reversible PTM and a major 
regulator of prote in activity or stability. Addition of negative charge from the phosphate 
group can cause major confonnational changes affecting the protein's interacting 
partners, localization and activity [39]. This regulation is so extensive that more than 
one third of aIl proteins are thought to be phosphorylated at any given time during their 
life cycle [84]. Since phosphorylation holds a central role in signaling networks, 
comprehensive phosphoproteome analysis is required to fully understand the signaling 
mechanisms through which IFN-y stimulates macrophage cells. Although, several 
antiviral effects of IFN-y are weIl known, no extensive study on the phosphoproteomic 
kinetics of early time-points has yet been generated on macrophage cells. 
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Large-scale phosphorylation analysis on other organisms such as yeast, Jurkat 
and Hela cells has been already documented in the literature using proteome chip 
technology and mass spectrometry [80, 113, and 114]. For instance, Zheng et al. 
analyzed by MS the phosphorylation effect of IFN-a on Jurkat cells usmg 
esterification/IMAC combined with phosphotyrosine immunoprecipitation [84]. In the 
past few years, mass spectrometry combined with enrichment strategies became a 
method of choice for the detection of thousands of phosphopeptides due to its high 
sensitivity and speed of analysis [80, 115]. Yet, mapping of phosphorylation sites in 
positive ion mode is difficult because of low stoichiometry of phosphorylation and the 
phosphopeptide population is under-represented due to ionization suppression effects 
[79, 116]. Hence the combination of enrichment (Ti02 and IMAC) and separation 
(Strong Cation Exchange & SDS-PAGE) procedures with the liquid chromatographic 
mass spectrometry (LC-MS) analysis is essential to enhance phosphopeptides detection 
[5, 114]. 
Large-scale mass spectrometry analyses generate sizable lists of 
phosphoproteins which require bioinformatic and data mining tools for comprehensive 
identification. Few tools are available to correlate proteins together and assemble 
networks. For instance, STRING generates protein-protein interaction maps using 
published two-hybrid studies or identification of interacting partners by affinity 
purifications and mass spectrometry [117]. Furthermore, additional information can be 
revealed on activated signaling pathways by determining the kinase motifs on detected 
phosphopeptides using kinase prediction tools and motif-x [118]. 
Here, we present a sensitive MS-based phosphoproteomic approach combined 
with Ti02 enrichment to profile changes in cytosolic phosphoprotein abundances in 
response to IFN-y activation ofmouse macrophage cellline 1774. We used a label-free 
detection method along with a peptide and a Fuzzy c-means clustering (FMC) method 
to profile phosphopeptide dynamics up to 180 min following IFN-y administration. The 
most significant changes occurred 5 and 30 min after macrophage activation. 
Subsequently, 2D-LC/MS analysis on Ti02-enriched phosphopeptides activated for 0,5 
& 30 min with IFN-y generated 2831 unique phosphopeptides. Functional 
(phosphoproteins network) combined with non-labeled expression-based proteomics 
enabled the identification of activated signaling pathways in macrophages. Transduction 
pathways linked to apoptosis, rnRNA translation, ROS production and phospholipid 
signaling were found to be modu1ated by phosphorylation changes upon IFN-y 
treatment. 
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3.3 Experimental Procedures 
3.3.1 Materials 
Sequencing Grade Modified Trypsin was obtained from Promega (Madison, WI 
US). Acetonitrile (ACN) and formic acid (FA) were purchased from Fisher Scientific 
(Whitby, ON, Canada). Ammonium bicarbonate was obtitined from EM Science 
(Mississauga, ON, Canada). Ammonium hydroxide, trifluoroacetic acid (TF A), OTT, 
iodoacetamide, imidazole and sucrose were purchased from Sigma-Aldrich (Oakville, 
ON, Canada). BCA protein assay and bond breaker TCEP solution were purchased from 
Pierce (Rockford, IL). Fetal bovine serum (FBS), penicillin-streptomycin, L-glutamine 
and OME/High glucose Oulbecco's modified eagle's medium were obtained from 
HyClone (Perbio, Nalgene). 
3.3.2 Cell cultures, protein extraction and trypsin digestion 
The preparation of 1774 murine macrophage cells and cytosolic protein 
extraction is described in detail in Marcantonio et al. [116]. For IFN-y challenge 
experiments, 1774 cell cultures were incubated for 0,5, 10,30,60 and 180 min with 100 
V/mL mouse IFN-y (PBL Biomedical Lab). 
Since phosphopeptides were isolated with Ti02 micro-tips, precipitated cytosolic 
proteins were resuspended in 1 % SOS/50 mM ammonium bicarbonate. Proteins were 
reduced in 0.5 mM TCEP for 20 min at 37°C and then alkylated in 50 mM 
iodoacetamide for 20 min at 37°C. 50 mM OTT was added to the prote in solution to 
react with excess iodoacetamide. Total protein amount was quantitated by BCA protein 
assay. Prote in digestion was performed in 0.1 % SOS, 50 mM ammonium bicarbonate 
with Sequencing Grade Modified Trypsin ovemight at 37°C and high agitation speed (1 
Ilg trypsin: 100 Ilg protein). The digest mixture was acidified with TF A and then 
evaporated to dryness. 
3.3.3 Phosphopeptide isolation 
The Ti02 enrichment procedure was performed as described before [53, 116]. 
The 2,5-dihydroxybenzoic acid (OHB) was replaced by lactic acid to avoid interference 
in 20-LC analysis. For the 10-LC-MS analysis, 20 ilL of acidified eluate was injected 
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on the LTQ-Orbitrap mass spectrometer. For the SCX-LC-MS analysis, eluates from 
five Ti02 micro-columns were pooled together, acidified with TF A and then evaporated 
to dryness. Samples were resuspended in 10 /lL of 0.2% formic acidJ 2% ACN and 
completely injected on the LTQ-Orbitrap mass spectrometer. Unless otherwise 
indicated, samples were prepared in triplicate for each condition. 
3.3.4 Le-MS/MS analyses and Mascot data base searching 
In this study, ID- and 2D-LC-MS analyses were performed on the LTQ-
Orbitrap hybrid mass spectrometer (Thermo Electron, San Jose, CA) coupled to a nano-
flow LC (Eksigent, Dublin) with a Spark-Holland autosampler (Thermo Electron, San 
Jose, CA) as described previously [116]. The 2D-LC-MS experiment comprised also a 
SCX column (300 A and 5 /lm, Nanoease Wàters) on line with the pre-column and 
analytical column. Peptides were eluted from the SCX column using five different 
ammonium acetate salt pH 3.0 fractions (0, 50, 100,500 & 2000 mM) in 0.2% FAI2% 
ACN. In this case, the CI8 analytical gradient started from 2% to 33% B over 54 min 
followed by a gradient from 33% to 60% over 10 min with a flow rate of 600 nL/min 
(A: 0.2% FA in water, B: 0.2% FAin ACN). 
Subsequently, aIl MS/MS spectra were processed through Mascot Distiller (version 
2.1.1, Matrix Science) and Mascot (version 2.1, Matrix Science, London, UK) software. 
A Mascot search against a concatenated targetldecoy database consisting of a combined 
forward and reverse version of the lPI mouse database (v3.24) was performed to 
establish a cutoff score threshold for a false-positive rate of less than 1 % (p < 0.01) 
[88]. 
3.3.5 Peptide detection and clustering 
Raw data files (.raw) generated from the LTQ-Orbitrap acquisition software 
were converted into csv files representing aIl ions according to their corresponding m/z 
values, retention time, intensity and charge state using in-house peptide detection 
software [78]. Intensity values above a user-defined intensity threshold (10,000 counts) 
were considered. Clustering of peptides across different samples was performed using 
in-house software. Upon obtaining Mascot search results, the clustering program 
matched each Mascot entry to a peak top from the MS data. The matching between MS 
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and MS/MS is based on the correlation of similarity in m/z and retenti on time (±0.035 
mlz and ±l min) following time nonnalization. Peptides from different samples with 
similar m/z, retenti on time (±0.035 m/z and ±l min) and identical assigned sequences by 
Mascot are grouped together to fonn clusters. Using the cluster average m/z and 
corrected retenti on time, peptides from samples where no MS/MS or no Mascot search 
results were obtained, are then added. ln order to confidently add peptides, a list of 
neighbors in the surrounding area (±5 m/z and ±4 min) is compared against a reference 
list of neighbors for each cluster. A minimum of three common neighbors must exist 
before a peptide is added to a cluster. The generated unique list of peptide clusters 
allowed the direct comparison of peptide abundance between samples in different 
conditions to identify those showing reproducible andstatistically meaningful changes 
in abundance. 
3.3.6 Fùzzy c-means clustering 
Temporal profiles of phosphopeptides' clusters for each lFN-y incubation time 
were created using a fuzzy c-means (FMC) clustering software titled "Soft clustering of 
time series gene expression data" (Mfuzz, 2007, v 1.6.0) available at 
http://itb.biologie.hu-berlin.de/-futschik/software/RlMfuzz/index.html. A detailed 
description of the FMC clustering device is found in Olsen et al. [80]. Only 
phosphopeptides with intensity values found in at least two of the three replicates of 
each condition were used for the plotting. Raw intensities instead of ratios were taken 
for the generation of time profiles. The cluster number (c) and the fuzzification 
parameter (m) were 6 and 1.5, respectively, since most defined and significant kinetic 
trends were obtained. 
3.3.7 Kinase and motif prediction tools 
The Prediction of PK-specific Phosphorylation site (PPSP), NetworKIN and 
Motif-x analyses were perfonned on ail identified phosphopeptides with a Mascot score 
>25 and also on up- & down regulated phosphopeptides with at least 2-fold change and 
a p-value <0.1. 
F or kinase motif prediction, a Perl script automated with the PPSP software (2006, LCD 
& USTC) was used to detennine the kinase consensus site with a high specificity 
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(http://bioinfonnatics.lcd-ustc.org/PPSP/). PPSP was proven to be a very powerful and 
accurate tool holding a large number of prote in kinase groups [119]. The search was 
perfonned against mouse IPI database. 
Concomitantly, protein kinases targeting phosphorylation sites were also established 
using NetworKIN software (v2.0, 2008) (http://networkin.info/search.php).This tool 
not only considers consensus sequence motifs like PPSP but also the direct or indirect 
protein association networks from STRING database [120]. ln doing so, the linked 
experimental prediction of the kinases responsible for the identified phosphopeptides 
improves the accuracy and confidence level. In this case, the human database was used 
for the kinase prediction since NetworKIN considers human and mouse species to have 
very similar protein coverage and characteristics. 
Over-represented patterns from phosphopeptides sequence were extracted using 
motif-x software (http://motif-x.med.harvard.edulmotif-x.html.v 1.2 10.05.06, 2005) 
[118]. Motif-x's strategy consists of building successive motifs and comparing it to a 
dynamic statistical background. Identified phosphosites were centered with six amino 
acids flanking on each side of the hydroxyamino acid. Parameters set for the width, 
occurrences, significance and background were 13, 20, 0.000001 and IPl Mouse 
Proteome, respectively. 
3.3.8 Phosphoprotein networking 
Mapping of the phosphoproteins interactions was perfonned using Search Tooi 
for the Retrieval of lnteracting Genes/Proteins (STRING) database (version 7.1, 
1,513,782 proteins in 373 species, http://string.emble.del) and visualized with 
Cytoscape software (version 2.5.1) [121, 122]. At first, non-redundant phosphopeptides 
with Mascot score < 25 from replicates of ail three conditions (0, 5 & 30 min) were 
converted to Ensembl peptide ID. Then the network was created with STRING software 
using mou se and human database to detennine the functional partners of each protein. 
The active prediction methods selected for STRING search were Experiments and 
Databases. The confidence level was set to medium (0.4) and no more than 10 
interactors were shown. Additional nodes, network depth and edge scaling factor 
parameters were set to 0, 2 and 80%, respectively. 
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3.4 ResuIts 
3.4.1 Phosphorylation dynamics of IFN-y treated J774 phosphopeptides 
Upon IFN-y priming, macrophages undergo several morphological and 
phenotypical changes. Several studies already reported the importance of protein 
phosphorylation in IFN-y activating signaling pathways [3, 9]. Yet no extensive kinetic 
study was ever performed. on the phosphoproteome of cytokine stimulated macrophage 
cells. Here, we present the tirst study on early changes in protein phosphorylation 
following IFN-y administration to J774 mouse macrophage cells. 
The experimental method consisted of initially extracting cytosolic proteins 
from J774 cells treated with IFN-y at different time-points (0, 5, 10,30,60 & 180 min). 
The digested cytosolic protein extract was enriched with Ti02 micro-columns proving a 
high enrichment and recovery of phosphopeptides [53, 123]. The outline of the sample 
work flow is shown in Figure 3.1. 
-107 cells/plate 
E 3 
+ 100 U/mL IFN-y 
! 1 III l 
o 5 10 30 60 180 min 
Cytosolic protein extraction 
Trypsin digestion 
Ti02 enrichment 
AlI time-points 
Bioinformatic analyses 
Dynamic c1uster profiling 
Protein phosphorylation network 
Figure 3.1: Overview of the analytical strategy and data mining approaches for 
time-resolved phosphoproteomics. J774 mouse macrophage cells were 
incubated with IFN-y for 0,5, 10,30,60 & 180 min. Cytosolic protein digest 
was enriched with Ti02 micro-tips and analyzed on a LTQ-Orbitrap mass 
spectrometer. AIso, a SCX-LC-MS/MS analysis was performed on Ti02-
enriched 0, 5, & 30 min IFN-y treated macrophages. In-house bioinformatic 
software processed the data for subsequent FMC clustering and network 
protein mapping. 
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The first part of the experiment consisted of determining the IFN-y incubation 
times that displayed the most significant changes in phosphorylation of the cytosolic 
proteins. According to Zheng et al. [84] kinetic assay, phosphorylation events were 
mediated rather quickly upon IFN-a cellular priming. Hence, shorter time-points (5, 10 
& 30 min) were selected accordingly to detect early ons et of phosphorylation events. In 
addition, longer time-points (60 & 180 min) were chosen to identify much later 
signaling events before the synthesis of new proteins. 1774 cytosolic protein digest 
treated for 0, 5, 10, 30, 60 & 180 min with IFN-y were enriched with Ti02 micro-
columns and detected by LC-MS/MS. To search for patterns in time profiles of 
identified phosphopeptides (Mascot score >25), 416 phosphopeptide clusters having at 
least an intensity value for two of three replicates for each condition were further 
clustered using a c-fuzzy means (FMC) algorithm [80]. For optimal partitioning of the 
time profiles, the cluster sizes (c-value) and the fuzzification parameter (rn-value) were 
optimized to 6 and 1.5, respectively. Each phosphopeptide profile is denoted by a color 
to determine the level of membership to its cluster. Pink-red, green-blue and yellow-
orange colors suggest high, medium and low association to the trend, respectively. As a 
result, four different clusters displayed interesting temporal changes of phosphorylation 
(Fig. 3.2). The first trend consisted of a general dephosphorylation (93 
phosphopeptides) taking place upon IFN-y administration where li 2-fold decrease in 
phosphorylation change occurred after 180 min (Fig. 3.2a). Aiso 80 peptide clusters 
showed a maximum in phosphorylation upon 30 min of macrophage activation (Fig. 
3.2b). Lastly, phosphorylation (57) and dephosphorylation (42) upon 5 min of cytokine 
stimulation were also noted as important clusters from the computed kinetic profiles 
(Fig. 3.2c-d). 
The kinetic analysis of 1774 cytosol extracts stimulated by IFN-y demonstrated 
that most phosphorylation changes took place upon 5 and 30 min of macrophage 
stimulation. Hence more extensive study was performed on these two kinetic time-
points to understand the implication of prote in phosphorylation in different IFN-y 
activated signaling pathways. 
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Figure 3.2: Clustered profiles of dynamic phosphorylation. Kinetic profiles showing 
(a) dephosphorylation, phosphorylation abundance increase at (b) 30 min 
and (c) 5 min, and (d) decrease at 5 min upon lfN-y stimulation. Each trace 
colour is coded according to the membership value col our code bar where 1 
corresponds to the best fit in the profile. 
3.4.2 Statistical analysis of macrophage phosphoproteome 
The second set of ex periment consisted of combining Ti02 enrichrnent and SCX 
separation with C I 8 analytical chromatography to enhance the number of 
phosphopeptides identification for 0, 5 and 30 min lfN-y stimulated J774 cells. This 
SCX-based strategy was already proven to efficiently retain hydrophilic peptides and 
significantly enhance phosphopeptide identification [115]. In aIl, 2831 phosphopeptides 
with a Mascot score >25 were identified across fractions and replicates of ail three 
conditions, indicating a faise positive rate of less than 1 %. Interestingly, 3201 
phosphorylation sites were deterrnined where 1673 (52%) sites have never been 
documented in the Swiss-Prot and Phospho ELM database. AIso, a high number of 
singly (2481) and doubly (334) phosphorylated peptides were detected further 
supporting the Ti02 specificity towards mono-phosphopeptides compared to IMAC 
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enrichment [54, 116]. The serine, threonine and tyrosine proportion from the total 
amount ofisolated phosphopeptides was 85, 13 and 2%, respectively (Table 3.1). 
Table 3.1: Statistics on overall distribution of phosphopeptides from IFN-y stimulated 
J774 kinetic study 
Category 
# Assignment 
# Phosphoproteins 
# Phosphopeptides 
# Phosphorylation sites 
# Novel phosphory1ation sites identified 
# Phosphopeptides with 1, 2, 3 or 4 phospho sites 
Phosphory1ated residues (Ser:Thr:Tyr) 
No. of examples 
5420 
1084 
2831 
3201 
1673 (52%) 
2481,334,14,1 
85%,13%,2% 
Following phosphopeptide detection and clustering, volcano plots representing 
the change in abundance and p-values distribution of peptide clusters across control and 
5 & 30 min IFN-y treated samples were obtained (Fig. 3.3). The x-axis represents the 
fold change between the two conditions and the y-axis indicates the p-value for at-test 
of differences between both samples. From the spiked a-casein phosphopeptides, an 
average CV < 23% was obtained for the change in intensity throughout aIl replicates of 
every condition. Phosphopeptides are considered up or down-regulated if they represent 
clusters with change in abundance > 2-fold with p-values < 0.05 (dotted regions Fig. 
3.3). In aIl, 1841 phosphopeptide clusters (80.6 %) had similar intensities in the control 
and 5 min IFN-y-treated sample whereas 145 (6.3 %) and 299 peptide clusters (13.1 %) 
were 2-fold down and up-regulated, respective1y (Fig. 3.3a). Similarly, 1722 
phosphopeptide clusters (75 %) were within 2-fold change for the control sample 
compared to 30 min IFN-y treated sample and 164 (7.1 %) and 411 peptide clusters 
(17.9 %) were down and up-regulated, respectively (Fig. 3.3b). 
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Figure 3.3: Volcano plot distribution of (a) 5 and (b) 30 min IFN-y treated cytosolic 
extracts of J774 cells. Only phosphopeptides with a Mascot score >25 and 
intensity values found in ail or none of the three replicates were considered. 
SoUd line divides peptide clusters more abundant in control and IFN-r 
samples. Dashed lin es delimit peptide populations showing 2-fold change in 
abundance with l'-values <0.05. Numbered squares identify ail up- and 
down-regulated phosphopeptides listed in Table 3.2. 
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From the large number of phosphopeptides obtained, bioinformatic tools were 
required to de termine which pathways were activated during IFN-y priming. Data were 
first analyzed with kinase prediction and motif-x softwares to indicate what type of 
kinases might be inhibited or activated upon IFN-y signaling. NetworKIN software 
specifically determined the kinases responsible for the phosphorylation on serine, 
threonine and tyrosine residues. NetworKIN holds more meaningful statistical level 
than other kinase prediction tools since it considers the consensus motif and the protein 
association between the kinase and substrate [120]. The five most significant kinases 
(>80 phosphopeptides) for the 5 and 30 min time-points were Cell division protein 
kinase 2 (CDK2), Casein kinase 2 (CK2), TGF-beta receptor type-2 (TGFBR2), 
Serine/threonine-protein kinase Pim-2 (PIM2) and Mitogen-activated protein kinase 14 
(MAPK14, p38). Figure 3.4 shows aIl kinases that were matched to at least 45 
phosphopeptides with their proportion (%) of substrate that have at least 2-fold change 
in phosphorylation with p-values < 0.1 upon macrophage activation. As a result, no 
kinase seemed to significantly phosphorylate less upon IFN-y administration. On the 
other hand, CDK2, MAPK14 and CK2 were notably more active upon 5 and 30 min 
IFN-y stimulation. AIso, PPSP prediction further confirmed the induction of CK2 
motifs. Interestingly, these kinases have different consensus motifs where CDK2 and 
MAPK14 have a proline-directed phosphorylation site (SIT-P) whereas CK2 is an 
acidic-residue directed kinase (X-pS-X-X-E/D) [124-126]. Kinases potentially 
associated with these changes in phosphorylation are involved in a multitude of 
important cellular function such as protein synthesis, cell cycle regulation and gene 
transcription [126-128]. 
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Figure 3.4: NetworKIN kinase prediction of identified phosphopeptides. Upon (a) 5 
and (b) 30 min IFN-y stimulation, the kinases which phosphorylated peptides 
up- and down-regulated upon macrophage activation with p-values < 0.1 
were shown as black and striped bars, respectively. Only kinases matched to 
at least 45 substrates were represented on the graph. 
Furthermore, not only different types of kinases were characterized through 
NetworKIN but also, a more detailed analysis of the substrate motif was generated 
using motif-x software. A list of 29 different over-represented patterns for serine and 
threonine phosphorylation was computed across the non-redundant phosphopeptide list 
(3134 phosphopeptides with Mascot score >25). The motifs were subsequently divided 
into 5 categories of proline, acidic residue, arginine, bipolar and serine-directed (Fig. 
3.5). The most frequently observed category for J774 phosphopeptides was the proline-
directed motifs comprising 51.6% of aIl phosphopeptides. Yet, the highest number of 
different patterns (15) was obtained for 'the acidic residue-directed motifs. 
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Figure 3.5: Over-represented motif-x patterns of ail identified phosphopeptides. 
Five different kinds of motifs were identified: (a) proline-directed, (b) acidic 
residue-directed, (c) arginine-directed, (d) bipolar-directed and (e) serine-
directed. 
Also, motif-x computed the over-represented patterns for ail phosphopeptides 
showing 2-fold change in abundance with p-value < 0.1 upon IFN-y treatment. As a 
result, acidic residues and proline directed motifs were the frequently observed patterns 
showing changes in abundance (Fig. 3.6). 
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Figure 3.6: Over-represented motif-x patterns of differentially expressed 
phosphopeptides. Mainly proline and acidic residue-directed motifs 
were identified for up and down-regulated phosphopeptides with a p-
value < 0.1. 
3.4.3 Network analysis in signaling pathways of activated macrophages 
Strategies were implemented to provide a more comprehensive analysis of this 
large-scale experiment. AlI non-redundant phosphopeptides detected in 0, 5 and 30 min 
IFN-y treated samples (Mascot scores >25) with known Ensemb/ identification were 
processed througb STRING database. Cytoscape software was used to visualize maps 
illustrating the interactions between different phosphoproteins . As a result, 715 
phosphoproteins were integrated in the network with known interacting partners in the 
literature. Lnterestingly, several known IFN-y stimulated pathways such as NAPDH 
oxidase, apoptosis, rnRNA translation, and phospholipid signaling pathways were 
identified (Fig. 3.7). Even though, these pathways were already known to play 
important functions during IFN-y induction, man y novel phosphorylated proteins were 
identified from this kinetic study. 
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Figure 3.7: 
Phosphoprotein interaction 
networks of J774 
macrophages. 
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A network showing the 
interaction between unique 
phosphoproteins (715) present 
in 0, 5 & 30 min IFN-y treated 
cells. Most populated and 
activated signaling pathways 
were apoptosis, mRNA 
translation phospholipids and 
cytotoxic molecules 
production. The boxes have a 
circular, rectangular and 
hexagonal shape depending if 
the phosphoproteins are under-
or over- expressed in both 
conditions, after 5 or 30 min of 
IFN-y exposure, respectively. 
Aiso the boxes are coloured in 
white, red and blue when the 
phosphoprotein does not 
change significantly, is under 
or over-expressed, respectively. 
Ali phosphoproteins 
differentially expressed had a 
p-value < 0.1. 
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To obtain the complete biological representation of phosphoproteins role and 
changes, the identified phosphoproteins from STRING network were correlated with 
their expression data. Accordingly, phosphoproteins showing 2-fold up-, down-
regulation or no change upon IFN-y treatment were colored in red, blue and white, 
respectively. AIso, for each sub-network examined a rectangle, a hexagon or an oval 
represent changes occurring after 5 and 30 min IFN-:y incubation or in both conditions, 
respectively (Fig. 3.7). AU macrophage phosphopeptides showing significant changes in 
intensity changes (at least 2-fold) with p-values <0.1 are listed in Table 3.2. Sorne of 
these phosphopeptides are represented by numbered squares on the volcano plots (Fig. 
3.3). For exarnple, ribosomal prote in S6 kinase alpha-3, eukaryotic translation initiation 
factor 4B and proto-oncogene vay phosphoproteins were dephosphorylated upon 
cytokine stimulation. In contrast, p67PhO", inositol polyphosphate phosphatase-like land 
inhibitor of nuclear factor kappa B kinase subunit beta were phosphorylated upon 
macrophage activation. 
ln addition, this analysis enabled to deterrnine the IFN-y exposure time required 
for phosphorylation changes and signaling activation to occur in specific pathways. For 
instance, most phosphoproteins involved in the rnRNA translation pathway significantly 
changed phosphorylation state after 5 min of IFN-y treatment. On the other hand, later 
signaling events took place 30 min upon IFN-y stimulation and were mainJy illustrated 
in the apoptotic network. Interestingly, many phosphoproteins identified in the cell 
death network were part of the classicaJ apoptotic pathway. Figure 3.8 illustrates the 
apoptotic signal transduction including most identified phosphoproteins from the 
STRING analysis. Key molecules such as NF-KB, 26S proteasome and PEA-15, had 
considerable phosphoryJation changes upon cytokine priming. 
In surnrnary, 2D-LC-MS/MS analysis of Ti02-enriched 1774 ceIl extract 
combined with prote in network predictions identified many important pathways 
suggesting novel phosphorylation regulation for the mediation of IFN-y biological 
effects. 
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Figure 3.8: Classical apoptotic signaling pathways highlighting phosphoproteins 
identified upon 5 and 30 min IFN-y. Phosphorylated proteins are 
represented with a white, red and blue phosphate group corresponding to 
no changes, up- and down- regulation upon IFN-y stimulation, 
respectively. 
Table 3.2: Phosphopeptides showing differential abundance in 5 and 30 min IFN-y stimulated J774 cytosol extracts 
Fold change 
Phosphopeptides Proteins Function 5min 30 min 
AYpSFCGTVEYMAPEVVNR Ribosomal protein S6 kinase alpha-3 
GL V AA YSGDpSDNEEEL VER RNA-binding protein 5 
pSPPEGDTTLFLSR Death inducer-obliterator 1 isoform 3 
TSEDTSSGpSPPKK Apoptosis inhibitor 5 
TPATTASpSPVTTAQVHCLPL Nuclear factor NF-kappa-B p'105 subunit 
SSSSTR 
GPVSGpSPDSMNVSR 
DIIRQPpSEEEIlK 
HIVNGAKPNTESEElpSpSED 
DELVGEK 
SGV A VPTpSPK 
KEVQpSPEQVK 
KGpSITEYTA TEEK 
LSQVNGApTPVpSPIEPESK 
lnhibitor of nuclear factor kappa B kinase 
subunit beta 
Astrocytic phosphoprotein PEA-15 
Apoptosis-antagonizing transcription 
factor . 
Programmed cell death protein 4 
Bcl-2-associated transcription factor 1 
BCL2/adenovirus E1B 19 kDa prote in-
interacting protein 2 
Myb-binding protein lA 
TVGpTPIASVPGSTNTGTVPG 26S proteasome non-ATPase regulatory 
SEKDSDPMETEEK subunit 1 
(p-values) (p-values) 
Apoptosisl -77.5 -77.5 
mRNA translation (0.0021) (0.0021) 
Apoptosis 
Apoptosis 
Apoptosis 
Apoptosis 
Apoptosis 
Apoptosis 
Apoptosis 
Apoptosis 
Apoptosis 
Apoptosis 
Apoptosis 
Apoptosisl 
Proteasome 
-2.2 -1.6 
(0.0138) (0.1306) 
2.5 2.9 
(0.0145) (0.0453) 
2.0 2.1 
(0.0169) (0.0160) 
1.8 2.2 
(0.0495) (0.0502) 
1.6 2.3 
(0.0197) (0.0436) 
-3.4 -38.0 
(0.0056) (0.0003) 
3.5 3.5 
(0.0722) (0.0354) 
1.9 3.3 
(0.1245) (0.0289) 
1.8 49.2 
(0.0772) (0.0310) 
3.1 3.7 
(0.0463) (0.0060) 
-1.7 -3.34 
(0.0344) (0.0002) 
. -33.8 -33.8 
(0.0019) (0.0019) 
92 
92 
93 
Proteasome 8.0 8.9 ApSGEMASAQYlT AALR Ubiquitin specifie protease 14 isoform 2 {0.1036} {0.0277} 
DMPGGFLFDGLpSDDEDDFH 2.1 1.8 Ubiquitin-1ike protein 7 Proteasome {0.0326} {0.2083} PSTR 
GTPase activating protein and VPS9 Endocytosis -3.4 -1.2 pSSDIVSSVR domains 1 {0.0095} (0.3620} 
GTPase activating protein and VPS9 Endocytosis -2.5 -1.0 SRpSSDIVSSVR domains 1 (0.0428} {0.8853} 
Endocytosis 2.6 1.9 EFEpSGDFQDFTR AP-1 subunit gamma-binding protein 1 {0.0242} {0.3529} 
Endocytosis -1.9 -2.1 TPpSSEEISPTKFPGL YR RaJA -binding prote in 1 (0.0440} {0.0421} 
Endocytosis -1.5 -3.2 TASESISNLSEAGpSVK Restin {0.0509} {0.0006} 
Vesicle 2.1 2.3 HSSLPTEpSDEDIAPAQR AP-3 complex subunit delta-1 {0.0374} (0.0306} 
Vesicle -2.7 l.2 VPpSMESLFR Golgin subfamily A member 4 (0.0192} {0.6733} 
Cytoskeleton 2.0 1.9 pSPEEDQQAFRPLEK nestin (0.0124) (0.0073) 
Cytoskeleton -3.4 -4.3 VSQVSLESLEKENVQpSPR nestin {0.0197) (0.0121) 
Cytoskeleton 2.2 2.4 pSLEGENHDPLSSVVK nestin {0.0728} (0.0015} 
Cytoskeleton -11.6 -11.6 MpSGFIYQGK BetaPix-bL {0.0034} {0.0034} 
Cytoskeleton 2.5 4.4 IDElpSDKETEVEESSEK F ormin binding protein 30 {0.0306} {0.1651} 
Cytoskeleton -2.5 -1.7 ARLTHFLAQCpTR FH1/FH2 domain-containing protein {0.0381} (0.0769} 
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Putative RNA-binding prote in Luc7-like 
mRNA translation -4.9 -1.0 AMLDQLMGTpSR 2 {0.O175} {0.9982) 
DSGNWDTSGSELpSEGELEK Pre-mRNA-processing factor 40 homo log 
mRNA translation 15.4 29.8 R A {0.0190} {0.0103} 
Negative elongation factor E mRNA translation -1.9 -2.2 SMpSADEDLQEPSR {0.0286} (0.0061} 
Negative e1ongation factor E rnRNA translation -8.1 -8.1 SLpSEQPVVDTATATEQAK {0.0049} (0.0049} 
Serine/threonine-protein kinase SMG 1 rnRNA translation -1.4 -2.1 NLA TSADpTPPSpTIPGTGK (0.0962} (0.0259} 
Transcription elongation factor SPT5 mRNA translation -3.8 -1.1 DVTNLTVGGFTPMpSPR (0.0184} {0.8322) 
Eukaryotic translation initiation factor 3 
mRNA translation 2.8 2.3 pSPSQEPSAPGK S9 {eta} {0.0219} {0.0325) 
60S acidic ribosomal protein P2 rnRNA translation -3.3 -1.8 KEESEEpSDDDMGFGLFD {0.0274} {0.1596} 
GA TPAEDDEDKDIDLFGpSD Elongation factor 1-delta mRNA translation 3.7 3.5 EEEEDK (0.0276} (0.1119) 
IEpSDAQEPAEPEDDLDIMLG Eukaryotic translation initiation factor 2 
mRNA translation -2.4 -1.2 NK subunit 2 (eIF-2-beta) (0.0287) (0.6228} 
DDDDIDLFGpSDDEEESEEA Elongation factor 1-beta mRNA translation 2.9 2.4 K {0.0418} (0.0150} 
YAALSVDGEDEDEGDDCpT Eukaryotic translation initiation factor 4B mRNA translation -2.0 -2.3 E {0.0466} {0.0532} 
Histidyl tRNA synthetase 2 mRNA translation -1.1 3.9 SASpSGAEGDVSSEREP {0.4411} {0.0078} 
EGVILTNENAApSPEQPGDE tRNA (cytosine-5-)-methyltransferase 
mRNA translation 2.0 1.9 DAK NSUN2 {0.0398} {0.0116} 
Exosome complex exonuclease RRP46 mRNA translation 2.3 2.9 pSPVCSLR (0.0628} {0.0280} 
94 
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p67phOX ROS production 2.6 2.9 pTPEIFR {0.00661 {0.0079} 
ROS production -2.0 -1.2 IGWFPSNYVEEDYSEpYC Proto-oncogene vav {0.0104} {0.2194} 
FSEMMDHMGGDEDVDLPEV Prostaglandin E synthase 3 PGE2 production -6.2 -6.2 DGADDD~SQD~SDDEK {0.0007} (0.0007} 
lnositol polyphosphate phosphatase-like 1 Phospholipid 6.7 4.7 VFDQQSpSPMVTR (SHIP-2} (0.0200) (0.1259) 
SH3-domain kinase-binding protein 1 Phospholipid -2.0 -1.0 pSIEVENDFLPVEK (RUK) (0.0310) (0.9388} 
Ribosomal protein S6 ·kinase delta-l Phospholipid 2.1 2.9 GVDLLLEGVQGESpSPTR {R~s6kc1) {0.1123} (0.04021 
lnositol hexakisphosphate and 2.1 2.0 FFHHAEEEEEEEDEpSPPER diphosphoinositol-pentakisphosphate Phospholipid (0.0363) (0.0383) kinase 2 
Thyroid hormone receptor-associated Transcription 2.1 2.2 FSGEEGEIEDDEpSGTENR [!rotein 3 {0.0088î {0. 1337î 
Thyroid hormone receptor-associated Transcription 2.3 2.7 pSPLQSVVVR Erotein 3 {0.0451} (0.0485} 
W AHDKFpSGEEGEIEDDESG Thyroid hormone receptor-associated Transcription 2.3 3.0 
TENR Erotein 3 (0.0596) (0.0406) 
Transcriptional regulator A TRX Transcription 2.0 2.0 EVIEIEDApSPTK {0.0764} (0.0266) 
Transcription 1.4 2.5 EVIEIEDApSPTKCPITTK Transcriptional regulator A TRX {0.2542} {0.0446} 
Transcription 2.0 2.1 VFIDQNLpSPGK Transcription factor Dp-I {0.0022} {0.0001} 
95 
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3.5 Discussion 
In this study, MS-based strategy provided evidence that several cell signaling 
pathways are directed by phosphorylation events upon IFN-y stimulation. Tracking 
changes in phosphorylation at different time-points was not performed by Western blot 
since general antibodies against phosphoserine and threonine are not specific enough to 
detect accurate phosphorylation dynamics [37]. Serine and threonine residues hold 
chemical structures very similar to other acidic residues which decrease their specificity 
[37]. Even though tyrosine residues hold a distinct ring structure, antibodies directed 
against a specific phosphorylation site are still more sensitive than general anti-pTyr 
antibodies. For instance, Zheng et al. [84] evaluated the optimal IFN-a treatment 
conditions by Western blot using pTyr701 STAT1 and a mixture oftwo anti-pTyr (1:1) 
antibodies. As a result, the change in tyrosine phosphorylation was only assessed by 
pTyr701 ST A Tl antibody since the general anti-pTyr antibody detected no differences 
between control and treated samples [84]. For this reason, phosphopeptide enrichment 
procedure combined with mass spectrometry analysis and label-free quantification 
consisted as one of the best options for the evaluation of serine, threonine and tyrosine 
phosphorylation temporal profiles. 
Similarly to kinetic studies performed with other cell stimulating agents, the first 
most important trend of phosphorylation changes immediately took place after 5 min of 
IFN-y stimulation [84, 129, and 130]. Zheng et al. [84] showed that activation of 
macrophages induced important changes in phosphotyrosine levels upon 5 and 10 min 
IFN-a treatment. In general, tyrosine phosphorylation is known to be attributed to 
earlier signaling events. Since a higher proportion of phosphorylated serine and 
threonine residues were detected in our samples, activation of later signaling events was 
observed following 30 min of cytokine stimulation. On the. whole, 60 and 180 min lFN-
y stimulation always held a phosphoprotein level similar to the resting ce Ils [131]. One 
trend depicted the decrease in phosphorylation upon macrophage priming during the 
en tire time profile. These proteins dephosphorylated throughout the whole time course 
probably function as important modulators of macrophage activation. OveralI, the 
phosphoproteomic dynamics of stimulated macrophages portray early signaling events 
occurring in the cytosol that subsequently reach the nucleus and activate transcription 
factors of IFN-y regulated genes. 
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ln the second part of the study, the experiment was repeated with control, 5 and 
30 min IFN-y stimulated cells. A total of 2831 non-redundant phosphopeptides was 
identified and correlated with other high-throughput phosphoproteomic studies [80, 
115]. Since only the cytosolic part of macrophages was analyzed, a higher proportion 
(85% & 13%) of peptides was found to be phosphorylated on serine and threonine 
residues [1I5]. 
In addition, label-free quantitative phosphoproteomics enabled reproducible 
detection and identification of phosphopeptides. These results are consistent with those 
reported earlier by our group showing that ~ 70% of aIl phosphopeptide population does 
not change following IFN-y stimulation [116]. The remarkable duty cycle and 
sensitivity of the LTQ-Orbitrap enabled the identification of a large number of 
phosphopeptides. As shown on the volcano plots, few down-regulated phosphoproteins 
such as RSK-2 and 26S proteasome, had similar fold changes during early and late 
signaling events. ln contrast, other phosphoproteins such as Myb-binding protein lA, 
were differentially phosphorylated only after 5 or 30 min IFN-y stimulation. 
High-throughput tandem MS generated an exhaustive list of phosphoproteins, 
which necessitated bioinformatics analysis to gain more insight on the possible groups 
of kinases involved. From the NetworKIN software, three different kinases, CDK2, 
CK2 and MAPKl4 played important roles during IFN-y signaling. lnterestingly, motif-
x analyses were consistent with those ·obtained from NetworKIN indicating that 
phosphopeptides showing higher abundance changes comprised proline and acidic 
amino acids in their consensus motif. Identification of key kinases indicated which 
pathways are stimulated upon cytokine priming. For instance,CK2 is a serine/threonine 
kinase involved in numerous cellular functions including the maintenance of cell 
viability and protein synthesis [127]. From the kinetic study, CK2 substrates were 
phosphorylated after 5 and 30 min IFN-y administration with 9 & ll-fold increase, 
respectively. Interestingly, previous reports indicated that CK2 coordinates cell 
signaling events by phosphorylating IRF-I upon IFN-y treatment [132]. AIso, CK2 
phosphorylates NF-KB (p65 subunit) for its activation and possible translocation to the 
nucleus [133]. Finally, the identified elongation factor l-beta phosphopeptide 
(GATPAEDDEDKDIDLFGpSDEEEEDK, Ser lO6) was reported to be phosphorylated 
by CK2 [134]. Our study showed that phosphorylation on elongation factor l-beta (Ser 
98 
106) increased 2.9 and 2.4-fold upon 5 & 30 min cytokine activation. The kinase motif 
and prediction analysis suggested that IFN-y stimulation of macrophages led to the 
regulation of rnRNA translation and apoptotic pathways. Yet, further data analysis was 
performed to strengthened this observation and discover other possible primed protein 
networks. 
Characterization of the molecular partners of aIl phosphoproteins using STRING 
software gave further insights on plausible transduction pathways and their biological 
functions. Since this analysis was only based upon a sub-population of the ceIl, 
interaction maps lacked the presence and inter-connection of many non-phosphorylated 
partners. Also, major phosphoproteins from the popular JAK-STAT pathway were not 
identified probably since this signaling network occurs very rapidly within the first 
minute of IFN-y activation [9]. Still, several other important networks were identified to 
provide an overview of the IFN-y activated signaling pathways. 
One interesting network was composed of phosphoproteins involved in PI3'K 
signaling pathway known to be activated by IFN type 1 and II [11]. Upon extracellular 
stimuli, phosphoinositide concentration is regulated through activated phospholipases C 
(PLCs), phosphoinositide kinases and phosphatases. For instance, SH2 domain 
containing inositol 5-phosphatase 2 (SHIP-2) and phosphatase and tensin homologue 
deleted on chromosome ten (PTEN) dephosphorylate PI(3,4,5)P3 into PI(3,4)P2 and 
PI( 4,5)P2, respectively. These phosphoinositide such as PI( 4,5)P2 are required for the 
cytoskeleton rearrangement which uItimately leads to cell movement to reach the area 
of infection [33]. Interestingly, SHIP-2 was ~ 7 times more phosphorylated upon IFN-y 
stimulation on Ser24 1 (VFDQQSpSPMVTR). Upon phosphorylation, SHIP-2 is 
translocated to the cytosol suggesting that IFN-y stimulation may favour 
dephosphorylation of PI(3,4,5)P2 into PI( 4,5)P2 by PTEN for the remodelling of actin 
filaments [13 5]. 
The second phosphoprotein map portrayed sorne key molecules involved in the 
formation of NAPDH oxidase and ROS production. IFN-y induces the formation of 
NADPH oxidase complex through the phosphorylation and membrane recruitment of 
cytosolic proteins, p47ph0X, p40Phox and p67phox [101, 136]. In this study, we observed the 
increase in phosphorylation of the p67phox (pTPEIFR, Thr 233) prote in upon 5 and 30 
min of cytokine stimulation indicating an active recruitment ofNADPH complex for the 
production of cytotoxic molecules. 
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From the STRING network, it was also observed that important phosphoproteins 
part of the rnRNA translation initiation pathway underwent major phosphorylation 
changes. Our study showed that protein synthesis phosphorylation mainly occurred 5 
min upon IFN-y treatment since the initiation step is tightly regulated and must occur 
quickly to ensure proper control of rnRNA translation [22]. Inflammatory signaIs 
activate many transduction pathways such as Ras-MAPK and PI3K1Akt/mTOR, which 
in tum regulate the specific activity of key translation factors [22, 29, 30]. For instance, 
PI3K signaling network modulates eukaryotic translation initiation factor 2 beta (eIF2B) 
phosphorylation [107]. Welsh et al. [137] demonstrated that phosphorylation of Ser540 
by glycogen synthase kinase-3 (GSK-3) inactivates eIF2B complex hence translation 
initiation. From our IFN-y analysis, eIF2B was found to be dephosphorylated 
(IEpSDAQEPAEPEDDLDIMLGNK, SerI05) after 5 min of IFN-y stimulation. The 
phosphorylation effect on its activity during translation is still unknown. Depending on 
the cellular context, PI3K1Akt/mTOR pathway might activate or inhibit mRNA 
translation to respond to IFN-y stimulation [138]. 
The last major prote in network which displayed key phosphorylated molecules 
involved in cell defensive mechanism against infection was the apoptotic pathway. 
Commonly, IFN-y signaling pathways inhibit cell death in order to produce necessary 
pro teins to flght against inflammation [3]. On the other hand, apoptosis may also be 
promoted by IFN-y to kill tumour cells [25]. Our data suggest that IFN-y potentially 
activates the apoptotic pathway. Interestingly, most phosphoproteins were differentially 
regulated upon 30 min of IFN-y in arder to prioritize the stimulation of other more 
important pathways such as mRNA translation. 
The phosphoproteins identified from the network are part of the classical death 
receptor pathway which is triggered by pro-inflammatory cytokines such as TNF-a 
[139]. The signaling cascade is initially activated by the recruitment of TNF-R-
associated death domain protein (TRADD), receptor-interacting prote in (RIP), TNF-
receptor-associated factor 2 (TRAF2) and Fas-associated death domain protein (F ADD) 
to the tumor necrosis factor receptor superfamily member lA (TNF-R1a) [135, 140, 
141]. No changes in abundances were detected on the identified phosphoproteins FADD 
(Ser 191, already documented) and TNF-R1a (Ser70, unknown) [142]. Site-directed 
mutagenesis of PEA-15 (Seri 16) suggested that its phosphorylation promotes binding 
to FADD and blocks apoptosis [143]. From our analysis, a decrease (-3.37 and -38.0 
fold change upon 5 and 30 min) in phosphdrylation takes place upon IFN-y for the 
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phosphopeptide DIIRQPpSEEEIIK (Ser 116) indicating most probably that apoptosis is 
activated. 
These membrane proteins further recruits the NEMO complex and activates 
MEKK which is responsible for IKKp phosphorylation [144]. IKKp activation is 
important and essential for nuclear factor-kappa B (NF -KB) activation by inflammatory 
responses since it phosphorylates IKBa [145]. Ribosomal protein S6 kinase alpha-3 
(RSK-2) is also responsible for the phosphorylation of IKBa [146]. Interestingly, both 
phosphoproteins, IKKp (Ser 672, GPVSGpSPDSMNVSR) and RSK-2 (Ser 227, 
A YpSFCGTVEYMAPEVVNR), were detected as differentially regulated upon IFN-y 
activation. The exact role of these phosphorylation sites is still not documented in the 
literature. 
Usually NF-KB is found in the cytoplasm in the inactive fonn bound to the 
inhibitory IKB. Upon phosphorylation, IKBa liberates its lysine residues and becomes a 
target to 26S proteasome [146]. Upon IFN-y treatment, phosphorylation of 26S 
proteasome is significantly decreased [147]. Similar observations were noted where 
TVGpTPIASVPGSTNTGTVPGSEKDSDPMETEEK (Thr 273) had a decrease of 
phosphorylation of -34 fold upon 5 and 30 min IFN-y stimulation. Regrettably, 
phosphorylated IKB was not identified in our study probably due to its relatively low 
abundance in cytosol extracts upon its rapid degradation by 26S proteasome. After IKB 
degradation, NF-KB is Iiberated and can freely enter the nucleus to activate gene 
J 
transcription of specific IFN-y mediated genes [140]. Interestingly, NF-KB (pl05/p50) 
phosphopeptide (TPA TT ASpSPVTT AQVHCLPLSSSSTR, Ser 895) was also identified 
with a 2.2 fold increase in intensity upon 30 min IFN-y priming. Yet, the exact function 
of this phosphorylation site still not clearly defined. 
In addition, aIl phosphoproteins found in these functional networks were linked 
with their corresponding kinase using NetworKiN software. As a result, CK2 and 
CDK2 were responsible for the phosphorylation of most proteins in aIl clusters. No 
specific kinase activated one of the functional networks except for p38, which was 
found to only phosphorylate Ser 672 of I-kappa-B-kinase beta in the apoptotic pathway. 
Even thought the phosphorylation site is known, no proof has been documented in the 
literature regarding a possible connection between p38 and the I-kappa-B-kinase beta 
pathway. 
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In summary, Le-MS approaches. combined with prote in network analysis led to 
a more comprehensive characterization of many pathways affected by IFN-y_ We 
identified known and novel phosphorylation sites from proteins involved in the 
apoptotic and mRNA translation pathways, NAPDH complex formation and 
phospholipids signaling network providing new insights on the cellular response to IFN-
y activation. Quantitative phosphoproteomics revealed an unsurpassed level of 
molecular details on cytokine activation and cell signaling towards a better 
understanding of IFN-y as a therapeutic agent against viral and microbial infections_ 
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In signal transduction pathways, protein phosphorylation is the most 
abundant and studied PTM. Recent advancement in mass spectrometry and affinity 
chromatography enabled the detection of phosphopeptides of very low abundance 
leading to a better understanding of phosphoprotein function in cell signaling. Yet, 
phosphopeptides do not efficiently ionize in positive ion mode due to the presence of 
the phosphate group, making their detection difficult. Hence, the tirst part of my report 
described the application of AP treatment for the enhanced detection of TiOrenriched 
J774 phosphopeptides. 
Initially, the novel Ti02 enrichment procedure was evaluated for large-scale 
phosphoproteomic studies. To ensure maximal phosphopeptide enrichment of J774 cell 
extract, the loading capacity, sensitivity and linear dynamic range of Ti02 micro-
columns was assessed. The Ti02 technique demonstrated a greater enrichment (-77%) 
and recovery level of phosphopeptides than the traditional IMAC extraction method. 
Interestingly, it was also noted that Ti02 micro-columns had higher affinity for singly 
phosphorylated peptides whereas IMAC micro-columns enriched more efficiently 
multi-phosphorylated peptides. The optimal amount of cell extract loaded on 1.25 mg 
Ti02 micro-column was 250 !lg. The L TQ-Orbitrap detected as low as 25 finol of 
spiked a-casein in Ti02-enriched cell extract. AIso, the linear recovery of spiked a-
casein digest showed that even phosphopeptides present in the complex sample wou Id 
yield a linear response across different abundance level. OveraIl, Ti02 enrichment 
method was proven to be reproducible and highly selective for phosphopeptide 
detection. 
Next, the alkaline phosphatase strategy was evaluated with a positive (a-casein) 
and negative (non-phosphorylated protein mixture) control. No signiticant changes in 
abundance were observed upon dephosphorylation of the non-phosphorylated prote in 
mixture. On the other hand, , alkaline phosphatase treatment on a-casein notably 
enhanced phosphopeptide detection especially of highly phosphorylated peptides. The 
incubation conditions of the alkaline phosphatase treatment were optimal since known 
a-casem phosphopeptides were not detected by mass spectrometry upon 
dephosphorylation. Yet, if ever incomplete dephosphorylation occurred to multiply 
phosphorylated peptides, the intensity of the dephosphorylated cognate might be lower 
and new doubly or triply phosphorylated peptides might appear upon alkaline 
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phosphatase treatment. To avoid such cases, correlation of the phospho- and 
dephosphorylated partners was only done with unique peptides detected in non-treated 
and AP-treated samples. 
The enzymatic approach was further validated with a complex mixture of 1774 
cell extract. The intensity and retention time of phosphopeptides and their 
dephosphorylated counterpart were compared using in-house bioinformatic tools. 
lnterestingly, the overall abundance of dephosphorylated peptides was -2 fold more 
intense than their corresponding phosphopeptide. AIso, 716 new putative 
phosphopeptides were identified only upon AP treatment. Since the peptide's 
hydrophobicity should increase upon phosphate group removal, an overall higher 
retention time was expected after enzymatic dephosphorylation. However, 
dephosphorylated peptides displayed variation of retention time as high as 5 min 
making them either more or less hydrophobic. The loss of hydrophobicity upon 
dephosphorylation was partially explained by the formation of salt bridges between the 
phosphate group and nearby acidic residue. a-Casein N-acetylated phosphopeptides 
showed a consistent increase in retention time upon dephosphorylation unlike the non-
derivatized phosphopeptides, further supporting the salt bridge model. ln brief, the AP 
treatment led to not only a higher phosphopeptide detection but also provided new 
insight of phosphopeptide behaviour in MS. 
Lastly, the analytical potentials of the AP approach were applied on 1774 
macrophage ce Ils treated with IFN-y for 5 min. Ti02 enrichment enabled the 
identification of 1143 phosphopeptides from 432 pro teins of which 125 
phosphopeptides showed at least 2-fold change upon IFN-y stimulation. Key 
phosphoproteins in the NADPH oxidase complex formation and rnRNA translation 
were detected to be differentially expressed upon IFN-y exposure. Upon AP treatment 
on Ti02-enriched samples, the humber of putative phosphopeptides nearly doubled and 
led to the identification of several other differentially phosphorylated proteins in IFN-y 
activated pathways. For instance, the putative phosphopeptide of AP-3 complex was 
found more abundant upon cytokine stimulation where this phosphorylation was already 
reported to participate in vesicle formation. 
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The IFN-y activation of macrophages showed that phosphorylated prote in played major 
roles in signal transduction. Up to now, the JAK-STAT pathway is the only weIl 
characterized cellular event triggered by IFN-y [19]. Many other signal transductions 
are recognized to be primed upon cytokine stimulation, but their signaling pathway is 
still not completely defined. Hence, the second part of the study reported for the first 
time a phosphoproteome dynamics of IFN-y primed macrophages. According to the 
phosphoproteome kinetic profiles, most significant phosphorylation changes occurred 5 
and 30 min upon lFN-y administration. Aiso a dephosphorylation pattern was observed 
throughout the whole time profile. 
Determination of important IFN-y triggered signaling pathways was achieved by 
SCX-LC-MS analysis of Ti02-enriched phosphopeptides incubated for 5 and 30 min 
with IFN-y. This high-throughput procedure enabled the identification of 2831 
phosphopeptides with a SerlThr/Tyr proportion of 85: 13:2. For the 5 and 30 min treated 
samples, -20 and 25% of phosphopeptide clusters had at least a 2-fold change in 
abundance, respectively. ln total, this sensitive MS-based strategy detected 1673 novel 
phosphorylation sites, providing new insights on lFN-y activated pathways. 
Different strategies were applied to determine the key cellular events that were 
affected by phosphoproteomic changes upon lFN-y treatment. Initially, a kinase 
prediction using NetworKIN software showed that most up-regulated phosphopeptides 
upon 5 and 30 min lFN-y treatment were phosphorylated by MAPK14, CK2 and CDK2. 
Also, the motif-x analysis demonstrated that most overrepresented patterns in 
differentially expressed phosphopeptides were acidic amino acid and proline-directed. 
Interestingly, the NetworKIN prediction was in concordance with motif-x results since 
MAPK14 and CDK2 have a Ser-Pro consensus motif and CK2 phosphorylates sites 
near acidic residues. These kinases play important roi es in a multitude of cellular 
events. For instance, CK2 phosphorylates proteins involved in the apoptotic and mRNA 
translation pathway. The elongation factor 1-beta phosphopeptide was up-regulated 
upon cytokine stimulation and was already documented to be phosphorylated by CK2 
[134]. AIso, CK2 activates NF-JeB by phosphorylation, which is implicated in cell 
death, initiation ofinflammatoiy responses, immunity and cell proliferation [133]. 
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The last part of the analysis consisted of characterizing the molecular partners of 
aIl phosphoproteins using STRlNG software. Four different phosphoproteins network 
maps were identified and corresponded to the activation of transduction pathways in 
apoptosis, protein synthesis, cytotoxic molecules formation and phospholipids. 
DifferentiaI phosphorylation in mRNA translation pathway occurred very quickly (5 
min) to tightly regulate translation factors in the initiation step. ln contrast, apoptosis 
signal transduction primarily took place during the late signaling events (30 min). Most 
phosphoproteins detected in the cell death network were associated with the classical 
apoptotic pathway. For instance, important kinases, RSK-2 and lKK~ known to 
phosphorylate IKBa were detected as differentially regulated upon cytokine stimulation. 
AIso, the abundance of phosphoprotein PEA-15 was significantly lowered upon IFN-y 
suggesting that cell death was activated since dephosphorylation of PEA-15 was shown 
to promote apoptosis [143]. 
To conclude, highly sensitive MS combined with SCX and Ti02 
chromatography enabled the characterization of macrophage inflammation resulting in a 
cascade of signaling events in apoptosis, prote in synthesis, NADPH oxidase formation 
and phospholipids signaling. In addition, the AP treatment led to the detection of several 
phosphoproteins necessary to respond to the IFN-y biological effects. Yet, the AP 
strategy had sorne limitations. For instance, the location of the exact phosphosite ofnew 
putative phosphopeptides containing multiple hydroxyamino acids could have not been 
identified. As an alternative, new phosphatases can be engineered to remove the 
phosphate group and also leave behind a marker with a different mass, which can 
pinpoint the phosphorylation site. AIso, the experiments for the alkaline phosphatase 
treatment cou Id have only been performed in ID-LC mode, which restricted the starting 
material to -250 !lg of peptides. On the other hand, the 2D-LC analysis used a much 
larger amount (1.25 mg) of digested proteins, which was initially enriched using Ti02 
micro-columns and then injected onto the LC/MS. As a result, this study offered a much 
higher level of phosphopeptide detection and enabled assessing the importance of NF-
Jd3 in inflammatory responses, which can be further investigated by site-directed 
mutagenesis of the protein's new phosphorylation site followed by protein's structure 
and function studies. Identification of novel IFN-y targets will help understanding 
macrophage activation pathways and provide knowledge for a fundamental 
immunological response important for many diseases. 
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